Yoshinobu Onuma
#131,071
Most Influential Person Now
Researcher
Yoshinobu Onuma's AcademicInfluence.com Rankings
Yoshinobu Onumacomputer-science Degrees
Computer Science
#5765
World Rank
#6085
Historical Rank
Computational Linguistics
#875
World Rank
#888
Historical Rank
Machine Learning
#1647
World Rank
#1669
Historical Rank
Artificial Intelligence
#1883
World Rank
#1915
Historical Rank
Download Badge
Computer Science
Yoshinobu Onuma's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Yoshinobu Onuma Influential?
(Suggest an Edit or Addition)Yoshinobu Onuma's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial (2008) (701)
- Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II (2013) (671)
- A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods (2009) (631)
- Assessment of the SYNTAX score in the Syntax study. (2009) (520)
- A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial (2015) (519)
- Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. (2010) (506)
- Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial (2016) (447)
- Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization? (2011) (392)
- Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. (2008) (358)
- Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents: A Prospective Cohort Study (2012) (337)
- Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes (2010) (336)
- Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study (2020) (290)
- From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? (2012) (287)
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018) (268)
- A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. (2015) (261)
- 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis (2016) (260)
- Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. (2014) (244)
- 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. (2010) (240)
- Bioresorbable scaffolds: rationale, current status, challenges, and future. (2014) (240)
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document (2018) (228)
- Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-l-Lactic Acid Coronary Stents: Igaki-Tamai Stents (2012) (224)
- Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial (2015) (221)
- Noncardiac findings in cardiac imaging with multidetector computed tomography. (2006) (213)
- Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials (2014) (210)
- Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial. (2013) (210)
- Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study (2017) (207)
- Identification of putative palytoxin as the cause of clupeotoxism. (1999) (205)
- First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study (2012) (204)
- Incidence and clinical impact of coronary stent fracture after sirolimus‐eluting stent implantation (2007) (203)
- Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherenc (2009) (195)
- Incomplete Stent Apposition Causes High Shear Flow Disturbances and Delay in Neointimal Coverage as a Function of Strut to Wall Detachment Distance: Implications for the Management of Incomplete Stent Apposition (2014) (192)
- Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings. (2015) (184)
- Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system--a Bern-Rotterdam Study. (2010) (175)
- Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach (2009) (167)
- 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy (2017) (155)
- Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial (2016) (154)
- A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up. (2016) (150)
- The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. (2009) (148)
- Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease (2018) (144)
- Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? (2012) (143)
- Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2012) (139)
- Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials (2017) (136)
- Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire - fractional flow reserve. (2014) (135)
- Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial. (2010) (133)
- Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications (2019) (131)
- Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial. (2016) (129)
- Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. (2012) (129)
- In vivo assessment of high-risk coronary plaques at bifurcations with combined intravascular ultrasound and optical coherence tomography. (2009) (124)
- ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease c (2012) (124)
- Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. (2021) (124)
- Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study. (2014) (123)
- Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. (2010) (122)
- Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study. (2010) (121)
- Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials. (2017) (121)
- Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial (2011) (118)
- Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging. (2017) (114)
- A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions. (2015) (113)
- Bioresorbable Scaffold: The Emerging Reality and Future Directions (2017) (112)
- Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Ev (2014) (111)
- Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study. (2014) (111)
- A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. (2010) (110)
- Comparison of in vivo acute stent recoil between the bioresorbable everolimus‐eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus‐eluting stent (2011) (109)
- Bioresorbable scaffold technologies. (2011) (109)
- Computed tomography in total coronary occlusions (CTTO registry): radiation exposure and predictors of successful percutaneous intervention. (2009) (107)
- Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial. (2013) (105)
- Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two‐year angiographic and three‐year clinical results from the SPIRIT II study (2010) (105)
- Prevalence of Carotid Artery Stenosis in Patients With Coronary Artery Disease in Japanese Population (2005) (102)
- Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis (2018) (100)
- Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease (2013) (98)
- Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up. (2015) (95)
- Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. (2018) (95)
- Angiographic and Optical Coherence Tomography Insights Into Bioresorbable Scaffold Thrombosis (2015) (95)
- Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice. (2013) (93)
- Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease. (2016) (93)
- Bioresorbable Vascular Scaffolds for Coronary Revascularization. (2016) (91)
- 3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification. (2010) (90)
- A novel dedicated quantitative coronary analysis methodology for bifurcation lesions. (2008) (88)
- First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography. (2011) (88)
- The future of drug-eluting stents. (2008) (87)
- Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials. (2017) (85)
- Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial (2012) (84)
- Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions. (2008) (81)
- Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD. (2018) (81)
- Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study). (2010) (80)
- Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. (2011) (79)
- Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous (2013) (78)
- Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. (2016) (78)
- The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial. (2016) (77)
- Efficacy of culprit plaque assessment by 64-slice multidetector computed tomography to predict transient no-reflow phenomenon during percutaneous coronary intervention. (2008) (74)
- 3D optical coherence tomography: new insights into the process of optimal rewiring of side branches during bifurcational stenting. (2014) (73)
- Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial. (2019) (72)
- Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial. (2019) (72)
- CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018 (2018) (72)
- Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus‐eluting stents (2007) (71)
- Relation between plaque type and dissections at the edges after stent implantation: an optical coherence tomography study. (2011) (71)
- Vulnerable plaques and patients: state-of-the-art. (2020) (71)
- Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. (2012) (70)
- The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry. (2009) (67)
- Parietal Dysgraphia: Characterization of Abnormal Writing Stroke Sequences, Character Formation and Character Recall (2007) (66)
- Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry. (2014) (64)
- Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Ro (2009) (63)
- Progress in treatment by percutaneous coronary intervention: the stent of the future. (2013) (63)
- Assessing bioresorbable coronary devices: methods and parameters. (2014) (62)
- 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials. (2011) (62)
- The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy. (2013) (62)
- A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial (2017) (62)
- Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography. (2011) (62)
- Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. (2021) (61)
- Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. (2011) (60)
- Evaluation of coronary artery bypass grafts and native coronary arteries using 64-slice multidetector computed tomography. (2007) (60)
- Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications. (2013) (60)
- Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials (2017) (60)
- The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology? (2012) (60)
- A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. (2011) (59)
- Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary (2018) (59)
- A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study. (2009) (58)
- 3-Dimensional bifurcation angle analysis in patients with left main disease: a substudy of the SYNTAX trial (SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery). (2010) (58)
- Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValving System (2009) (58)
- Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease. (2016) (57)
- One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial. (2018) (57)
- In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial. (2010) (56)
- Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up. (2016) (56)
- Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments. (2012) (56)
- Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. (2010) (56)
- Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study. (2019) (55)
- Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization. (2020) (55)
- Left main coronary artery disease: pathophysiology, diagnosis, and treatment (2018) (54)
- Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents. (2017) (54)
- Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II). (2015) (53)
- Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention (2016) (53)
- Avances en el tratamiento mediante intervención coronaria percutánea: el stent del futuro (2013) (53)
- Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease: Insights From the SYNTAX III REVOLUTION Trial. (2019) (53)
- Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial. (2016) (53)
- Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation (2020) (53)
- Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy. (2009) (53)
- Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial. (2018) (52)
- Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD: The ASET Pilot Study. (2020) (51)
- Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery). (2013) (50)
- The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial). (2010) (50)
- Late thrombotic events after bioresorbable scaffold implantation: a systematic review and meta-analysis of randomized clinical trials (2017) (49)
- 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials. (2014) (49)
- Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial (2019) (49)
- Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: the potential for clinical application. (2013) (49)
- Advances in stent drug delivery: the future is in bioabsorbable stents (2009) (49)
- Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trial. (2013) (49)
- The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardi (2010) (48)
- Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study. (2012) (48)
- Comparison of Outcome of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Non-ST-Elevation Acute Coronary Syndrome. (2017) (48)
- Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data. (2015) (47)
- 6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mm. (2011) (47)
- Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease. (2019) (47)
- Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study (2019) (46)
- Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry. (2008) (46)
- Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trial. (2014) (46)
- Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Long-Term Outcome After Bare Metal and Drug-Eluting Stent Implantation (2008) (46)
- Tissue characterization with depth-resolved attenuation coefficient and backscatter term in intravascular optical coherence tomography images (2017) (46)
- Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study. (2019) (45)
- Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. (2006) (45)
- Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT (2011) (45)
- The Impact of Coronary Physiology on Contemporary Clinical Decision Making. (2020) (45)
- Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial. (2015) (45)
- Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials. (2016) (45)
- Bioresorbable scaffolds in the treatment of coronary artery disease (2013) (44)
- First generation versus second generation drug‐eluting stents for the treatment of bifurcations: 5‐year follow‐up of the LEADERS all‐comers randomized trial (2016) (44)
- Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial. (2014) (43)
- Xience V™ everolimus-eluting coronary stent (2009) (42)
- Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs. (2019) (42)
- Bioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials (2012) (42)
- CT-SYNTAX score: a feasibility and reproducibility Study. (2013) (41)
- Advanced three-dimensional quantitative coronary angiographic assessment of bifurcation lesions: methodology and phantom validation. (2013) (41)
- Fusion of optical coherence tomographic and angiographic data for more accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation: comparison with intravascular ultrasound-derived reconstructions (2014) (41)
- Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study. (2010) (40)
- Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data. (2016) (40)
- Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial: Feasibility, Diagnostic Performance of Quantitative Flow Ratio, and Clinical Prognostic Value of Functional SYNTAX Score Derived From Quantitative Flow Ratio in Patients With 3-Vessel Disease. (2018) (40)
- Advances in IVUS/OCT and Future Clinical Perspective of Novel Hybrid Catheter System in Coronary Imaging (2020) (40)
- Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application. (2011) (39)
- Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients. (2015) (38)
- Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial. (2012) (38)
- Single or dual antiplatelet therapy after PCI (2017) (38)
- Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents. (2011) (37)
- Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass (2014) (37)
- In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: An OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial (2010) (36)
- Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial. (2019) (36)
- The Nidus for Possible Thrombus Formation: Insight From the Microenvironment of Bioresorbable Vascular Scaffold. (2016) (35)
- Validity and variability in visual assessment of stenosis severity in phantom bifurcation lesions: A survey in experts during the fifth meeting of the european bifurcation club (2012) (35)
- INTERVENTIONAL CARDIOLOGISTS OF THORAXCENTER. IMPACT OF SEX ON 3-YEAR OUTCOME AFTER PERCUTANEOUS CORONARY INTERVENTION USING BARE-METAL AND DRUGELUTING STENTS IN PREVIOUSLY UNTREATED CORONARY ARTERY DISEASE: INSIGHTS FROM THE RESEARCH (RAPAMYCIN-ELUTING STENT EVALUATED AT ROTTERDAM CARDIOLOGY HOSPIT (2009) (35)
- Serial optical frequency domain imaging in STEMI patients: the follow-up report of TROFI study. (2014) (35)
- Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus‐eluting bioresorbable vascular scaffold (2012) (34)
- Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts in a polylactide bioresorbable scaffold: evidence in vivo about the abluminal healing process. (2012) (34)
- Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials. (2010) (34)
- Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent. (2015) (34)
- Transcatheter aortic valve implantation: new developments and upcoming clinical trials. (2012) (34)
- Quantitative assessment of the stent/scaffold strut embedment analysis by optical coherence tomography (2016) (33)
- Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry. (2016) (33)
- Impact of culprit plaque composition on the no-reflow phenomenon in patients with acute coronary syndrome: an intravascular ultrasound radiofrequency analysis. (2008) (33)
- Six‐month clinical follow‐up of the tryton side branch stent for the treatment of bifurcation lesions (2011) (33)
- Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial. (2014) (32)
- Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5,433 patients enrolled in contemporary coronary stent trials. (2015) (32)
- A Novel Angiographic Quantification of Aortic Regurgitation After TAVR Provides an Accurate Estimation of Regurgitation Fraction Derived From Cardiac Magnetic Resonance Imaging. (2018) (32)
- Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds. (2013) (32)
- Shaking and Breaking Calcified Plaque: Lithoplasty, a Breakthrough in Interventional Armamentarium? (2017) (32)
- Agreement and reproducibility of gray‐scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold (2012) (31)
- Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded Arteries. (2017) (31)
- Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). (2014) (31)
- A pooled gender based analysis comparing the XIENCE V(R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis. (2010) (31)
- Inter-core lab variability in analyzing quantitative coronary angiography for bifurcation lesions: a post-hoc analysis of a randomized trial. (2015) (31)
- Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging. (2017) (31)
- Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy. (2009) (30)
- Bioresorption and Vessel Wall Integration of a Fully Bioresorbable Polymeric Everolimus-Eluting Scaffold: Optical Coherence Tomography, Intravascular Ultrasound, and Histological Study in a Porcine Model With 4-Year Follow-Up. (2016) (30)
- Acute performance of a novel restorative transcatheter aortic valve: preclinical results. (2017) (30)
- Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model (2015) (30)
- High-speed intracoronary optical frequency domain imaging: implications for three-dimensional reconstruction and quantitative analysis. (2012) (29)
- Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry. (2016) (29)
- Endothelial shear stress 5 years after implantation of a coronary bioresorbable scaffold (2018) (29)
- Impact of Implantation Technique and Plaque Morphology on Strut Embedment and Scaffold Expansion of Polylactide Bioresorbable Scaffold - Insights From ABSORB Japan Trial. (2016) (29)
- Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. (2017) (29)
- Percutaneous coronary intervention versus bypass surgery for left main coronary artery disease: a meta-analysis of randomised trials. (2011) (29)
- Ten-year follow-up of the IGAKI-TAMAI stent. A posthumous tribute to the scientific work of Dr. Hideo Tamai. (2009) (29)
- Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study (2021) (29)
- Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease. (2019) (29)
- Quantitative angiography methods for bifurcation lesions: a consensus statement update from the European Bifurcation Club. (2017) (29)
- Dmax for sizing, PSP-1, PSP-2, PSP-3 or OCT guidance: interventionalist's jargon or indispensable implantation techniques for short- and long-term outcomes of Absorb BRS? (2017) (29)
- First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial. (2017) (28)
- Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. (2016) (28)
- In vitro validation and comparison of different software packages or algorithms for coronary bifurcation analysis using calibrated phantoms: Implications for clinical practice and research of bifurcation stenting (2015) (28)
- IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus‐eluting device during the bioabsorption process (2010) (27)
- Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold (2011) (27)
- Sex Differences in All-Cause Mortality in the Decade Following Complex Coronary Revascularization. (2020) (27)
- Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies. (2013) (27)
- MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses. (2009) (26)
- Patient Selection and Procedural Considerations for Coronary Orbital Atherectomy System. (2015) (26)
- Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease (2021) (26)
- Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study. (2020) (26)
- From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI (2016) (26)
- Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study. (2013) (26)
- Midterm performance of a novel restorative pulmonary valved conduit: preclinical results. (2017) (26)
- A novel dedicated 3-dimensional quantitative coronary analysis methodology for bifurcation lesions. (2011) (25)
- Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II stu (2016) (25)
- Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone (2019) (25)
- CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022 (2022) (25)
- Outcomes of a dedicated stent in coronary bifurcations with large side branches: A subanalysis of the randomized TRYTON bifurcation study (2016) (25)
- Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial. (2011) (25)
- Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis (2011) (25)
- Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds? (2012) (25)
- Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial. (2017) (24)
- Coronary Computed Tomographic Angiography for Complete Assessment of Coronary Artery Disease: JACC State-of-the-Art Review. (2021) (24)
- Procedural and clinical outcomes of the Absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the Bioresorbable vascular Scaffold Evaluated At Rotterdam Cardiology Hospitals (B-SEARCH). (2014) (24)
- Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities (2013) (24)
- Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease. (2016) (24)
- Quantification by optical coherence tomography imaging of the ablation volume obtained with the Orbital Atherectomy System in calcified coronary lesions. (2016) (24)
- Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document. (2019) (23)
- Scaffold and edge vascular response following implantation of everolimus-eluting bioresorbable vascular scaffold: a 3-year serial optical coherence tomography study. (2014) (23)
- State of the art: the inception, advent and future of fully bioresorbable scaffolds. (2017) (23)
- Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization. (2021) (23)
- OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings. (2009) (23)
- Morphological and functional evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS, echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB A clinical trial (2010) (23)
- Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with (2013) (23)
- Five‐year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus‐eluting stents: Insights from the rapamycin‐eluting stent evaluated at Rotterdam Cardiology Hospital—(Research) Registry (2009) (23)
- Non-invasive fractional flow reserve: scientific basis, methods and perspectives. (2012) (23)
- Two‐dimensional quantitative coronary angiographic models for bifurcation segmental analysis (2011) (23)
- Strut protrusion and shape impact on endothelial shear stress: insights from pre-clinical study comparing Mirage and Absorb bioresorbable scaffolds (2017) (22)
- State of the art: coronary angiography. (2017) (22)
- The need for dedicated bifurcation quantitative coronary angiography (QCA) software algorithms to evaluate bifurcation lesions. (2015) (22)
- Advances in stent drug delivery: the future is in bioabsorbable stents. (2009) (22)
- Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study. (2016) (22)
- Intracoronary nicorandil prior to reperfusion in acute myocardial infarction. (2006) (22)
- Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy. (2018) (22)
- The SYNTAX score on its way out or … towards artificial intelligence: part I. (2020) (22)
- Angiographic late lumen loss revisited: impact on long-term target lesion revascularization (2018) (22)
- Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months. (2017) (22)
- New implication of three-dimensional optical coherence tomography in optimising bifurcation PCI. (2015) (22)
- Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts. (2014) (22)
- Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial. (2015) (21)
- Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI. (2019) (21)
- Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction. (2019) (21)
- Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial. (2015) (21)
- In vivo assessment of the three-dimensional haemodynamic micro-environment following drug-eluting bioresorbable vascular scaffold implantation in a human coronary artery: fusion of frequency domain optical coherence tomography and angiography. (2013) (21)
- Angiographic assessment of aortic regurgitation by video‐densitometry in the setting of TAVI: Echocardiographic and clinical correlates (2017) (21)
- 10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease. (2021) (21)
- Relationship between coronary artery remodeling and plaque composition in culprit lesions: an intravascular ultrasound radiofrequency analysis. (2007) (21)
- Restorative valve therapy by endogenous tissue restoration: tomorrow's world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration. (2017) (21)
- Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting (2021) (20)
- Differences in coronary risk factors, procedural characteristics, mortality and stent thrombosis between two all-comers percutaneous coronary intervention registries from Europe and Japan: a patient-level data analysis of the Bern-Rotterdam and j-Cypher registries. (2015) (20)
- Bifurcation lesions: Functional assessment by fractional flow reserve vs. anatomical assessment using conventional and dedicated bifurcation quantitative coronary angiogram (2010) (20)
- Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives (2012) (20)
- Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial (2018) (20)
- Snowshoe Versus Ice Skate for Scaffolding of Disrupted Vessel Wall. (2015) (20)
- Risk stratification in 3‐vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial (2015) (20)
- Novel bifurcation phantoms for validation of quantitative coronary angiography algorithms (2011) (20)
- An insight into the current use of drug eluting stents in acute and elective percutaneous coronary interventions in Europe. A report on the EuroPCI Survey. (2008) (20)
- Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. (2018) (19)
- Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 Valves. (2020) (19)
- Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial. (2019) (19)
- Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trial. (2020) (19)
- Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies (2011) (19)
- Intracoronary optical coherence tomography: Clinical and research applications and intravascular imaging software overview (2017) (19)
- Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery (2016) (19)
- Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation. (2017) (19)
- A simplified and reproducible method to size the mitral annulus: implications for transcatheter mitral valve replacement (2016) (19)
- Advances in two-dimensional quantitative coronary angiographic assessment of bifurcation lesions: improved small lumen diameter detection and automatic reference vessel diameter derivation. (2012) (19)
- Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2016) (19)
- Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry Results. (2018) (19)
- Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic Substudy. (2017) (18)
- Optical coherence tomography enables more accurate detection of functionally significant intermediate non-left main coronary artery stenoses than intravascular ultrasound: A meta-analysis of 6919 patients and 7537 lesions. (2020) (18)
- Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy. (2008) (18)
- Impact of renal insufficiency on safety and efficacy of drug‐eluting stents compared to bare‐metal stents at 6 years (2012) (18)
- Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study. (2017) (18)
- Shear Stress Estimated by Quantitative Coronary Angiography Predicts Plaques Prone to Progress and Cause Events. (2020) (18)
- Integration of non-invasive functional assessments with anatomical risk stratification in complex coronary artery disease: the non-invasive functional SYNTAX score. (2017) (18)
- Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated a (2011) (17)
- Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents. (2010) (17)
- Impact of coronary calcium on outcome following sirolimus-eluting stent implantation. (2011) (17)
- Preclinical assessment of the endothelial shear stress in porcine-based models following implantation of two different bioresorbable scaffolds: effect of scaffold design on the local haemodynamic micro-environment. (2016) (17)
- Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy. (2017) (17)
- Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study. (2019) (17)
- Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions (2015) (17)
- Feasibility of planning coronary artery bypass grafting based only on coronary computed tomography angiography and CT-derived fractional flow reserve: a pilot survey of the surgeons involved in the randomized SYNTAX III Revolution trial. (2019) (17)
- Initial characterization of Ikari Guide catheter for transradial coronary intervention. (2004) (17)
- Videodensitometric quantification of paravalvular regurgitation of a transcatheter aortic valve: in vitro validation. (2018) (16)
- Coronary plaque composition as assessed by greyscale intravascular ultrasound and radiofrequency spectral data analysis (2008) (16)
- Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study. (2011) (16)
- Are BVS suitable for ACS patients? Support from a large single center real live registry. (2016) (16)
- Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial. (2019) (16)
- Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry). (2014) (16)
- Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial. (2018) (16)
- Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging. (2016) (16)
- Impact of post‐procedural minimal stent area on 2‐year clinical outcomes in the SYNTAX II trial (2019) (15)
- Impact of Coronary Remodeling on Fractional Flow Reserve. (2018) (15)
- SYNTAX II and SYNTAX III trials: what is the take home message for surgeons? (2018) (15)
- Clinical endpoints in transcatheter aortic valve implantation: a call to ARC for standardised definitions. (2009) (15)
- Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years. (2020) (15)
- Single-vessel or multivessel PCI in patients with multivessel disease presenting with non-ST-elevation acute coronary syndromes. (2013) (15)
- 10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification. (2021) (14)
- Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions. (2021) (14)
- Edge Vascular Response After Resorption of the Everolimus-Eluting Bioresorbable Vascular Scaffold - A 5-Year Serial Optical Coherence Tomography Study. (2016) (14)
- Outcomes of Coronary Artery Bypass Graft Surgery Versus Drug‐Eluting Stents in Older Adults (2017) (14)
- Guidelines for reporting mortality and morbidity after cardiac valve interventions--need for a reappraisal? (2009) (14)
- DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCI. (2020) (14)
- Short- and long-term implications of a bioresorbable vascular scaffold implantation on the local endothelial shear stress patterns. (2014) (14)
- Intravascular multimodality imaging: feasibility and role in the evaluation of coronary plaque pathology (2017) (14)
- Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease (2021) (14)
- First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial. (2018) (14)
- The SYNTAX score on its way out or … towards artificial intelligence: part II. (2020) (14)
- Spatial distribution and temporal evolution of scattering centers by optical coherence tomography in the poly(L-lactide) backbone of a bioresorbable vascular scaffold. (2012) (14)
- Temporal evolution of strut light intensity after implantation of bioresorbable polymeric intracoronary scaffolds in the ABSORB cohort B trial-an application of a new quantitative method based on optical coherence tomography. (2014) (14)
- Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study. (2011) (14)
- Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy (2017) (14)
- In vivo characterisation of bioresorbable vascular scaffold strut interfaces using optical coherence tomography with Gaussian line spread function analysis. (2012) (13)
- Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold? (2016) (13)
- Everolimus-eluting bioabsorbable stent--Abbot Vascular programme. (2009) (13)
- Impact of non-respect of SYNTAX score II recommendation for surgery in patients with left main coronary artery disease treated by percutaneous coronary intervention: an EXCEL substudy. (2019) (13)
- Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients. (2009) (13)
- Four‐year clinical outcome of sirolimus‐ and paclitaxel‐eluting stents compared to bare‐metal stents for the percutaneous treatment of stable coronary artery disease (2010) (13)
- A novel synchronised diastolic injection method to reduce contrast volume during aortography for aortic regurgitation assessment: in vitro experiment of a transcatheter heart valve model. (2017) (13)
- Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves (2021) (13)
- Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study. (2015) (13)
- Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry. (2019) (13)
- Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilized acute coronary syndromes: rationale and design of the ASET pilot study. (2019) (13)
- Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis. (2016) (12)
- Final 3-Year Outcomes of MiStent Biodegradable Polymer Crystalline Sirolimus-Eluting Stent Versus Xience Permanent Polymer Everolimus-Eluting Stent (2020) (12)
- Difference in haemodynamic microenvironment in vessels scaffolded with Absorb BVS and Mirage BRMS: insights from a preclinical endothelial shear stress study. (2017) (12)
- The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy. (2013) (12)
- Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial). (2018) (12)
- Differential impact of five coronary devices on plaque size: insights from the ABSORB and SPIRIT trials. (2014) (12)
- Tools and Techniques - Clinical: SYNTAX score II calculator. (2016) (12)
- Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial (2021) (12)
- Bioresorbable Scaffolds : From Basic Concept to Clinical Applications (2017) (12)
- Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease (2021) (12)
- Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events (2020) (12)
- The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique. (2017) (12)
- TCT-49 Two-year clinical outcome of Everolimus-eluting bioresorbable scaffold vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial. (2016) (12)
- Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). (2010) (12)
- A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial. (2018) (12)
- Development and receding of a coronary artery aneurysm after implantation of a fully bioresorbable scaffold. (2015) (12)
- How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials. (2019) (12)
- Clinical outcomes after final kissing balloon inflation compared with no final kissing balloon inflation in bifurcation lesions treated with a dedicated coronary bifurcation stent (2014) (11)
- In vitro validation of coronary CT angiography for the evaluation of complex lesions. (2018) (11)
- Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. (2015) (11)
- Reproducibility of intravascular ultrasound radiofrequency data analysis (virtual histology) with a 45-MHz rotational imaging catheter in ex vivo human coronary arteries. (2015) (11)
- Validation of the updated Logistic Clinical SYNTAX score for all-cause mortality in GLOBAL LEADERS trial. (2019) (11)
- Clinical relevance of ticagrelor monotherapy following 1‐month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial (2020) (11)
- Pressure-mediated versus pharmacologic treatment of radial artery spasm during cardiac catheterisation: a randomised pilot study. (2017) (11)
- Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey Programme. (2009) (11)
- Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine. (2021) (11)
- Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds. (2017) (11)
- Mid-term outcomes of the Absorb BVS versus second-generation DES: A systematic review and meta-analysis (2018) (11)
- The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial (2020) (11)
- Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers. (2018) (10)
- Three-year clinical event rates in different age groups after contemporary percutaneous coronary intervention. (2011) (10)
- Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: from bench to clinical use (2015) (10)
- 3-dimensional optical frequency domain imaging for the evaluation of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. (2011) (10)
- Association of wall shear stress with long-term vascular healing response following bioresorbable vascular scaffold implantation. (2015) (10)
- External Validation of the SYNTAX Score II 2020. (2021) (10)
- Coronary Artery Bypass Grafting Versus Drug-Eluting Stents Implantation for Previous Myocardial Infarction. (2016) (10)
- Quantitative optical frequency domain imaging assessment of in-stent structures in patients with ST-segment elevation myocardial infarction: impact of imaging sampling rate. (2012) (10)
- Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model. (2017) (10)
- The Absorb bioresorbable vascular scaffold for the treatment of coronary artery disease (2016) (10)
- Comparison between two‐ and three‐dimensional quantitative coronary angiography bifurcation analyses for the assessment of bifurcation lesions: A subanalysis of the TRYTON pivotal IDE coronary bifurcation trial (2015) (10)
- Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document. (2018) (10)
- Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis: The COMPARE-ABSORB Randomized Clinical Trial. (2020) (10)
- Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial. (2017) (10)
- Accuracy of coronary computed tomography angiography for bioresorbable scaffold luminal investigation: a comparison with optical coherence tomography (2017) (10)
- Paravalvular Aortic Regurgitation Severity Assessed by Quantitative Aortography: ACURATE neo2 versus ACURATE neo Transcatheter Aortic Valve Implantation (2021) (10)
- Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TRO (2018) (10)
- Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial (2020) (10)
- The Impact of Renal Impairment on Long-Term Safety and Effectiveness of Drug-Eluting Stents (2014) (9)
- A Randomized Trial Evaluating Online 3-Dimensional Optical Frequency Domain Imaging–Guided Percutaneous Coronary Intervention in Bifurcation Lesions (2020) (9)
- Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials. (2019) (9)
- Coronary stent thrombosis: what have we learned? (2016) (9)
- The Effect of Strut Protrusion on Shear Stress Distribution: Hemodynamic Insights From a Prospective Clinical Trial. (2017) (9)
- Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males: Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled Trials. (2017) (9)
- Visual estimation versus different quantitative coronary angiography methods to assess lesion severity in bifurcation lesions (2018) (9)
- TCT-512 Bioabsorbable Vascular Scaffold Radial Expansion and Conformation Compared to a Metallic platform: Insights from In-vitro Expansion in a Coronary Artery Lesion Model (2015) (9)
- Safety and feasibility evaluation of planning and execution of surgical revascularisation solely based on coronary CTA and FFRCT in patients with complex coronary artery disease: study protocol of the FASTTRACK CABG study (2020) (9)
- Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stents. (2009) (9)
- Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial. (2019) (9)
- Impact of Multivessel Coronary Artery Disease With Versus Without Left Main Coronary Artery Disease on Long-Term Mortality After Coronary Bypass Grafting Versus Drug-Eluting Stent Implantation. (2017) (9)
- Post-implantation shear stress assessment: an emerging tool for differentiation of bioresorbable scaffolds (2018) (9)
- Predictors of Long-term Adverse Events After Absorb Bioresorbable Vascular Scaffold Implantation: A 1,933-Patient Pooled Analysis From International Registries. (2019) (9)
- Assessment of plaque evolution in coronary bifurcations located beyond everolimus eluting scaffolds: serial intravascular ultrasound virtual histology study (2013) (9)
- Coronary calcification as a mechanism of plaque/media shrinkage in vessels treated with bioresorbable vascular scaffold: A multimodality intracoronary imaging study. (2018) (9)
- The Sino Medical AccuFit transcatheter mitral valve implantation system. (2015) (9)
- Abstract 5998: Final Results of the HEALING 2B Trial to Evaluate a Bioengineered CD34 Antibody Coated Stent (GenousTMStent) Designed to Promote Vascular Healing by Capture of Circulating Endothelial Progenitor Cells in CAD Patients (2008) (8)
- Late outcome after intracoronary beta radiation brachytherapy: a matched-propensity controlled ten-year follow-up study. (2011) (8)
- Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study (2021) (8)
- Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. (2019) (8)
- Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available. (2021) (8)
- Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin Strut Sirolimus-Eluting Coronary Stent Supraflex: Two-Year Outcomes of the TALENT Trial. (2021) (8)
- Bioresorbable vascular scaffolds in the clinical setting (2013) (8)
- Early and late optical coherence tomography findings following everolimus-eluting bioresorbable vascular scaffold implantation in myocardial infarction: a preliminary report. (2015) (8)
- Quantitative aortography assessment of aortic regurgitation. Insight into a novel technique. (2019) (8)
- Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective. (2021) (8)
- Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial. (2020) (8)
- The Evolution of Data Fusion Methodologies Developed to Reconstruct Coronary Artery Geometry From Intravascular Imaging and Coronary Angiography Data: A Comprehensive Review (2020) (8)
- Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial. (2019) (7)
- Five-year follow-up of underexpanded and overexpanded bioresorbable scaffolds: self-correction and impact on shear stress. (2017) (7)
- Inter-Technique Consistency and Prognostic Value of Intra-Procedural Angiographic and Echocardiographic Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Implantation. (2018) (7)
- Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent? (2017) (7)
- Imaging-guided pre-dilatation, stenting, post-dilatation: a protocolized approach highlighting the importance of intravascular imaging for implantation of bioresorbable scaffolds (2018) (7)
- Future Directions of Drug‐Eluting Stents (2009) (7)
- Impact of Bleeding and Myocardial Infarction on Mortality in All-Comer Patients Undergoing Percutaneous Coronary Intervention (2020) (7)
- Efecto del armazón bioabsorbible liberador de everolimus en la aterosclerosis coronaria (2016) (7)
- On-line three-dimensional OFDI guided PCI vs. angiography guided in bifurcation lesions: design and rationale of the randomized OPTIMUM trial. (2019) (7)
- The Role of Quantitative Aortographic Assessment of Aortic Regurgitation by Videodensitometry in the Guidance of Transcatheter Aortic Valve Implantation (2018) (7)
- The future of BRS in bifurcations. (2015) (7)
- Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial (2020) (7)
- Impact of biodegradable versus durable polymer drug‐eluting stents on clinical outcomes in patients with coronary artery disease: a meta‐analysis of 15 randomized trials (2014) (7)
- Direct implantation of rapamycin-eluting stents with bioresorbable drug carrier technology utilising the Svelte coronary stent-on-a-wire: the DIRECT II study. (2016) (7)
- Unravelling the complexities of the coronary bifurcation: is this raising a few eyebrows? (2012) (7)
- Pre-procedural planning of coronary revascularization by cardiac computed tomography. (2022) (7)
- Imaging assessment of bioresorbable vascular scaffolds (2017) (7)
- Quantitative Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement With Videodensitometry in a Large, Real-World Study Population: Subanalysis of RESPOND and Echocardiogram Association. (2019) (7)
- Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial. (2022) (6)
- Impact of stent length and diameter on 10‐year mortality in the SYNTAXES trial (2021) (6)
- Feasibility of 320-row multi-detector computed tomography angiography to assess bioabsorbable everolimus-eluting vascular scaffolds (2016) (6)
- Feasibility study of a synchronized diastolic injection with low contrast volume for proper quantitative assessment of aortic regurgitation in porcine models (2018) (6)
- Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: insights from in vitro expansion in a coronary artery lesion model. (2016) (6)
- Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (6)
- Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events (2020) (6)
- Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial. (2017) (6)
- LONG-TERM OUTCOME OF THE UNRESTRICTED USE OF EVEROLIMUS-ELUTING STENTS COMPARED TO SIROLIMUS-ELUTING STENTS AND PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS: THE BERN-ROTTERDAM DIABETES COHORT STUDY (2012) (6)
- Pre-procedural Planning of Coronary Revascularization by Cardiac Computed Tomography : An Expert Consensus Document of the Society of Cardiovascular Computed Tomography. (2022) (6)
- Difference of culprit plaque composition between patients with and without pre-infarction angina: an intravascular ultrasound radiofrequency analysis. (2009) (6)
- Abstract 4347: Long-term Clinical Results Following Stenting of the Left Main Stem: Insights From RESEARCH and T-SEARCH Registries (2009) (6)
- Hemodynamic analysis of a novel bioresorbable scaffold in porcine coronary artery model (2018) (6)
- Intimal Flaps Detected by Optical Frequency Domain Imaging in the Proximal Segments of Native Coronary Arteries. (2013) (6)
- Revascularization in the high-risk patient: multivessel disease. (2007) (6)
- Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three‐dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial (2017) (6)
- TCT-37 Five-year Clinical Outcomes and Non-invasive Angiographic Imaging Results With Functional Assessment After Bioresorbable Everolimus-eluting Scaffold Implantation in Patients with De Novo Coronary Artery Disease (2012) (6)
- Current perspectives on bioresorbable scaffolds in coronary intervention and other fields (2021) (6)
- Absorb bioresorbable scaffold versus Xience metallic stent for prevention of restenosis following percutaneous coronary intervention in patients at high risk of restenosis: Rationale and design of the COMPARE ABSORB trial. (2019) (6)
- Concerns with the new SYNTAX score – Authors' reply (2021) (6)
- The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial (2019) (5)
- Predictors of long‐term outcomes after bypass grafting versus drug‐eluting stent implantation for left main or multivessel coronary artery disease (2017) (5)
- Magnetic navigation system assisted stenting of coronary bifurcation lesions. (2011) (5)
- Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended Survival study (2021) (5)
- Application of the MADS classification system in a “mega mammoth” stent trial: Feasibility and preliminary clinical implications (2018) (5)
- TCT-527 Long-term Clinical Outcomes of Patients Treated With The Everolimus-eluting Bioresorbable Vascular Scaffold. The BVS Expand Study (2015) (5)
- Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials. (2017) (5)
- Optical Coherence Tomography-Derived Changes in Plaque Structural Stress Over the Cardiac Cycle: A New Method for Plaque Biomechanical Assessment (2021) (5)
- The ultra-thin strut sirolimus-eluting coronary stent: SUPRAFLEX. (2020) (5)
- Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study. (2018) (5)
- Short-term effects of Nano + TM polymer-free sirolimus-eluting stents on native coronary vessels : an optical coherence tomography imaging study (2015) (5)
- Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound (2015) (5)
- Regional variation in patients and outcomes in the GLOBAL LEADERS trial. (2020) (5)
- Long-term outcome after statin treatment in routine clinical practice: results from a prospective PCI cohort study. (2012) (5)
- Impact of White Blood Cell Count on Clinical Outcomes in Patients Treated with Aspirin-Free Ticagrelor Monotherapy after Percutaneous Coronary Intervention: Insights from the GLOBAL LEADERS Trial. (2020) (5)
- Novel devices Bioresorbable scaffolds : rationale , current status , challenges , and future (2014) (5)
- What does the future hold for novel intravascular imaging devices: a focus on morphological and physiological assessment of plaque (2017) (5)
- First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis. (2017) (5)
- Impact of established cardiovascular disease on outcomes in the randomized global leaders trial (2019) (5)
- Predicting 2‐year all‐cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score (2021) (5)
- 3D reconstructions of optical frequency domain imaging to improve understanding of conventional PCI. (2011) (5)
- The edge vascular response following implantation of a fully bioresorbable device: 'a miss always counts'. (2012) (5)
- Impact of the Orbital Atherectomy System on a Peripheral Calcified Lesion: Quantitative Analysis by Intravascular Echogenicity. (2015) (5)
- Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial (2020) (5)
- Age and Functional Relevance of Coronary Stenosis: a Post-Hoc Analysis of the ADVISE II Trial. (2021) (5)
- Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial. (2022) (5)
- In vivo three dimensional optical coherence tomography. A novel imaging modality to visualize the edge vascular response. (2013) (5)
- Very Late Scaffold Thrombosis in Absorb BVS: Association With DAPT Termination? (2017) (5)
- ANGIOGRAPHIC MAXIMAL LUMINAL DIAMETER AND APPROPRIATE DEPLOYMENT OF THE EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD AS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY (2011) (5)
- Coronary artery bypass grafting versus percutaneous coronary intervention in ischaemic heart failure. Can reliable treatment decisions in high-risk patients be based on non-randomized data? (2021) (5)
- Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study. (2019) (5)
- Online Quantitative Aortographic Assessment of Aortic Regurgitation After TAVR: Results of the OVAL Study. (2021) (5)
- Angiography-Based 4-Dimensional Superficial Wall Strain and Stress: A New Diagnostic Tool in the Catheterization Laboratory (2021) (5)
- Serial volumetric assessment of coronary fibroatheroma by optical frequency domain imaging: insights from the TROFI trial (2018) (5)
- Twitterature: will social media have an impact on scientific journals? (2018) (5)
- DIFFERENCE IN HEMODYNAMIC MICRO-ENVIRONMENT IN VESSELS SCAFFOLDED WITH ABSORB BVS AND MIRAGE BRMS: INSIGHTS FROM A PRE-CLINICAL ENDOTHELIAL SHEAR STRESS STUDY (2017) (5)
- BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial. (2020) (5)
- Diagnostic concordance and discordance between angiography-based quantitative flow ratio and fractional flow reserve derived from computed tomography in complex coronary artery disease. (2022) (4)
- Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold? (2017) (4)
- Patient Selection for the CoreValve ReValving System (2009) (4)
- Role of Computed Tomography in Planning the Appropriate X-Ray Gantry for Quantitative Aortography of Post-transcatheter Aortic Valve Implantation Regurgitation. (2018) (4)
- Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II). (2018) (4)
- Impact of Body Composition Indices on Ten-year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial). (2021) (4)
- Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial. (2018) (4)
- Role of invasive imaging in acute and long‐term assessment of bioresorbable scaffold technology (2016) (4)
- Rather Thick, Yet Antithrombogenic: Is the Magmaris Scaffold a New Hope for Bioresorbable Coronary Scaffold? (2017) (4)
- The incidence and relevance of site-reported vs. patient-reported angina: insights from the ABSORB II randomized trial comparing Absorb everolimus-eluting bioresorbable scaffold with XIENCE everolimus-eluting metallic stent. (2016) (4)
- A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial (2019) (4)
- Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial. (2020) (4)
- TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold (2014) (4)
- Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. (2022) (4)
- Neointimal characteristics comparison between biodegradable-polymer and durable-polymer drug-eluting stents: 3-month follow-up optical coherence tomography light property analysis from the RESTORE registry (2019) (4)
- Have We Overdefined Periprocedural Myocardial Infarction to the Point of Extinction? (2021) (4)
- The impact of plaque type on strut embedment/protrusion and shear stress distribution in bioresorbable scaffold. (2019) (4)
- The 2010s in clinical drug-eluting stent and bioresorbable scaffold research: a Dutch perspective (2020) (4)
- ‘Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI’: a post hoc analysis of the randomized GLOBAL LEADERS trial (2021) (4)
- Predicted and Observed Mortality at 10-Years in Patients With Bifurcation Lesions in the SYNTAX Trial. (2022) (4)
- VASCULAR COMPLIANCE CHANGES OF THE CORONARY VESSEL WALL AFTER BIORESORBABLE VASCULAR SCAFFOLD IMPLANTATION IN THE TREATED AND ADJACENT SEGMENTS (2012) (4)
- Quantitative Angiographic Assessment of Aortic Regurgitation Following 11 TAVR Devices: An Update of a Multicenter Pooled Analysis (2022) (4)
- Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions (2017) (4)
- Long-term data of BRS presented at EuroPCR 2017 (Friday, 19 May). (2017) (4)
- Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial (2020) (4)
- Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial (2022) (4)
- Coronary artery bypass graft surgery versus drug-eluting stent implantation for high-surgical-risk patients with left main or multivessel coronary artery disease (2017) (4)
- In vivo visualisation by three-dimensional optical coherence tomography of stress crazing of a bioresorbable vascular scaffold implanted for treatment of human coronary stenosis. (2012) (4)
- Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial. (2022) (4)
- First-in-Man Trial of SiO2 Inert-Coated Bare Metal Stent System in Native Coronary Stenosis - The AXETIS FIM Trial. (2017) (4)
- Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin? (2021) (4)
- Twilight, the Dawn of a New Era of Aspirin-Free PCI? (2020) (4)
- Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial. (2020) (4)
- Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk. (2022) (4)
- TCT-36 One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSORB EXTEND Trials. (2013) (3)
- Coronary Artery Bypass Surgery Versus€Drug-Eluting Stent Implantation for€Left€Main or Multivessel Coronary Artery€Disease (2016) (3)
- - Dimensional Bifurcation Angle Analysis n Patients With Left Main Disease Substudy of the SYNTAX Trial ( SYNergy Between Percutaneous oronary Intervention With TAXus and Cardiac Surgery ) (3)
- Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial. (2021) (3)
- Chronic Hemodynamic Performance of a Biorestorative Transcatheter Heart Valve in an Ovine Model. (2021) (3)
- Usefulness of updated logistic clinical SYNTAX score based on MI‐SYNTAX score in patients with ST‐elevation myocardial infarction (2020) (3)
- TCT-429 Short- and intermediate- term clinical outcomes after implantation of everolimus-eluting bioresorbable scaffold in complex lesions : a prospective single-arm study - ABSORB Expand trial (2013) (3)
- Trade-Off Between Bleeding and Thrombotic Risk in Patients With Academic Research Consortium for High Bleeding Risk. (2021) (3)
- Optimal Dual Antiplatelet Therapy Duration for Bioresorbable Scaffolds: an Individual Patient Data Pooled Analysis of the ABSORB Trials. (2021) (3)
- Clinical outcomes of "complete, partially complete, and incomplete" revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents. (2016) (3)
- The time has come to use coronary computed tomography angiography in patients with multivessel coronary artery disease. (2019) (3)
- Multi-modality intravascular imaging for guiding coronary intervention and assessing coronary atheroma: the Novasight Hybrid IVUS-OCT system. (2021) (3)
- Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. (2013) (3)
- Implications of a bioresorbable vascular scaffold implantation on vessel wall strain of the treated and the adjacent segments (2014) (3)
- Impact of the orbital atherectomy system on a coronary calcified lesion: quantitative analysis by light attenuation in optical coherence tomography. (2015) (3)
- Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy (2020) (3)
- Ten-year all-cause mortality according to smoking status in patients with severe coronary artery disease undergoing surgical or percutaneous revascularization. (2020) (3)
- Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial). (2019) (3)
- Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial (2019) (3)
- TCT-360 Assessment of Heart Team’s Treatment Decision Variability: Insights from the SYNTAX III Revolution trial. (2018) (3)
- Mortality after multivessel revascularisation involving the proximal left anterior descending artery (2022) (3)
- The "A, B, C" of multiple statistical methods for composite endpoints. (2020) (3)
- Very Late Scaffold Thrombosis (3)
- TCT-365 Incomplete Stent Apposition Causes High Shear Flow Disturbances and Delay in Neointimal Coverage as a Function of Strut-to-wall Detachment Distance (2014) (3)
- Intravascular imaging assessment of pharmacotherapies targeting atherosclerosis: advantages and limitations in predicting their prognostic implications. (2022) (3)
- Bioresorbable drug-eluting scaffolds for treatment of vascular disease (2016) (3)
- Comprehensive Evaluation of Left Ventricle Dysfunction by a New Computed Tomography Scanner: The E-PLURIBUS Study. (2022) (3)
- Drug-eluting bioresorbable scaffolds in cardiovascular disease, peripheral artery and gastrointestinal fields: a clinical update (2020) (3)
- Cracking (the code of) coronary artery calcification to win the last battle of percutaneous coronary intervention: still in the middle of a rocky road. (2019) (3)
- Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication. (2020) (3)
- Major Infections after Bypass Surgery and Stenting for Multivessel Coronary Disease: An analysis of the randomized SYNTAX trial. (2020) (3)
- External Validation of the FREEDOM Score for Individualized Decision Making Between CABG and PCI. (2022) (3)
- Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial. (2022) (3)
- QUANTITATIVE ASSESSMENT OF ACUTE REGURGITATION FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: A MULTICENTER POOLED ANALYSIS OF 2,258 VALVES (2020) (3)
- Thrombotic arch in ST-segment elevation myocardial infarction: comparison between two-dimensional and three-dimensional optical frequency domain imaging. (2012) (3)
- Additional side branch stent placement in patients with long side branch lesions treated with the Tryton dedicated bifurcation side branch stent. (2013) (3)
- Essentials of quantitative angiography for bifurcation lesions. (2010) (3)
- Comparative assessment of “plaque/media” change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study (2016) (3)
- Fate of Bioresorbable Vascular Scaffold Metallic Radio-Opaque Markers at the Site of Implantation After Bioresorption. (2015) (2)
- DIFFERENCE IN HEMODYNAMIC MICRO ENVIRONMENT IN VESSELS SCAFFOLDED WITH ABSORB BVS OR MIRAGE BRMS: A PRE-CLINICAL STUDY OF ENDOTHELIAL SHEAR STRESS (2016) (2)
- Optical Coherence Tomography Assessment for Percutaneous Coronary Intervention of the Left Main Artery: The IDEAL-LM Trial. (2020) (2)
- A Prospective Multicenter Validation Study for A Novel Angiography-derived Physiological Assessment Software: Rationale and Design of the Radiographic imaging Validation and EvALuation for Angio-iFR (ReVEAL iFR) study. (2021) (2)
- Corrigendum to Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model (vol 227, pg 467, 2017) (2017) (2)
- TCT-41 A Prospective Multicenter Randomized All-Comers Trial to Assess the Safety and Effectiveness of the Ultra-Thin-Strut Sirolimus-Eluting Coronary Stent Supraflex: 2-Year Results of the TALENT Trial (2019) (2)
- EARLY, LATE AND VERY LATE INCIDENCE OF BIORESORBABLE SCAFFOLD THROMBOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS AND OBSERVATIONAL REGISTRIES (2017) (2)
- Intimal flaps detected by optical frequency domain imaging in the proximal segments of native coronary arteries: an innocent bystander? Insights from the TROFI Trial. (2013) (2)
- Data from real-world registries: can it guide development of the bioresorbable scaffolds of tomorrow? (2017) (2)
- Successful coronary artery bypass grafting based solely on non-invasive coronary computed tomography angiography. (2021) (2)
- Validation of Prosthetic Mitral Regurgitation Quantification Using Novel Angiographic Platform by Mock Circulation. (2021) (2)
- Reply: Composite endpoints in clinical trials - simplicity or perfection? (2022) (2)
- TCT-397 Effect of post-dilatation on device expansion and arterial healing following Everolimus-eluting bioresorbable stent (Absorb BVS) versus durable polymer everolimus-eluting metallic stent (EES) implantation in STEMI patients: substudy of ABSORB STEMI TROFI II. (2016) (2)
- The state-of-the-art coronary stent with crystallized sirolimus: the MiStent technology and its clinical program. (2020) (2)
- Impact of established cardiovascular disease on 10-year death after coronary revascularization for complex coronary artery disease (2021) (2)
- 5-Year Follow-Up of Coronary Revascularization in Diabetic Patients With Multivessel Coronary Artery Disease (2011) (2)
- Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study. (2017) (2)
- Determinants of success and hemodynamic impact of balloon postdilatation of self‐expanding transcatheter aortic valves (2018) (2)
- Angiography derived assessment of the coronary microcirculation: is it ready for prime time? (2022) (2)
- TCT-33 Intracoronary Optical Coherence Tomography and Histology of Overlapping Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: The Potential Implications for Clinical Practice (2012) (2)
- Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS). (2020) (2)
- Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS. (2019) (2)
- The paradigm of endothelium and stent thrombosis in DES. (2008) (2)
- Improvement in local haemodynamics 5 years after implantation of a coronary bioresorbable scaffold: a pulsatile non-Newtonian shear stress analysis. (2017) (2)
- Tools & techniques: risk stratification and diagnostic tools in left main stem intervention. (2011) (2)
- Comparison of Clinically Adjudicated Versus Flow-Based Adjudication of Revascularization Events in Randomized Controlled Trials. (2021) (2)
- SPIRIT II STUDY: EVALUATION OF THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 5-YEAR RESULTS (2010) (2)
- Optimisation of percutaneous coronary intervention: indispensables for bioresorbable scaffolds (2016) (2)
- Did the SYNTAX Score Pass the Test of Time? (2020) (2)
- What is it to become an octogenarian 40 years after the first angioplasty? (2017) (2)
- Quantitative Angiographic Assessment of Aortic Regurgitation After Transcatheter Implantation of the Venus A-valve: Comparison with Other Self-Expanding Valves and Impact of a Learning Curve in a Single Chinese Center (2021) (2)
- TCT-176 Implantation of Thin-Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With De Novo Coronary Artery Lesions: 2-Year Clinical and 6-Month Imaging Outcomes of the MeRes-1 Extend Trial (2019) (2)
- Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five years clinical outcomes of the randomised ABSORB II trial. (2020) (2)
- TCT-34 The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices - Insights from the ABSORB Cohort B trial using three-dimensional optical coherence tomography (2013) (2)
- Compositional volumetry of non-calcified coronary plaques by multislice computed tomography: an ex vivo feasibility study. (2009) (2)
- Sealing of calcified plaques after bioresorbable scaffold implantations: a five-year follow up (2016) (2)
- Local Hemodynamics: An Innocent Bystander or a Critical Factor Regulating Neoatherosclerotic Evolution? (2015) (2)
- Sustained safety and efficacy of the magnesium scaffold: does the Magmaris scaffold call for the return of BRS research… and randomised controlled trials? (2020) (2)
- The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial. (2020) (2)
- Serial intravascular ultrasound observations from the Tryton first-in-man study. (2014) (2)
- Unconfirmed Very Long-Term Clinical Benefit of Xience Over Cypher: Should We Reset Our Vision? (2019) (2)
- TCT-11 Five-year Follow up of the First in Man use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis; A Serial Multi-Imaging Modality Study (2015) (2)
- Freedom from long DAPT signals the demise of the bare-metal stent (2016) (2)
- Polymer-free Drug-Coated Coronary Stents. (2016) (2)
- Early strut protrusion and late neointima thickness in Absorb bioresorbable scaffold: A serial wall shear stress analysis up to five years. (2019) (2)
- Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond (2021) (2)
- The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial. (2018) (2)
- A prospective multicenter randomized all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the TALENT trial. (2018) (2)
- Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study. (2020) (1)
- Abstract 2570: The Unrestricted Use Of Paclitaxel-eluting Stents: Five-year Results Of The Research Registry (2008) (1)
- Two-year follow-up of the DESSOLVE III trial: bioabsorbable polymer sirolimus-eluting stent vs. durable polymer everolimus-eluting stent. (2019) (1)
- Appropriateness of the modality of revascularization according to the SYNTAX Score II 2020 in the FASTTRACK CABG study: An interim report on patient selection. (2023) (1)
- TCT-326 Diagnostic Performance of Angiography-Based Quantitative Flow Ratio With Respect to Fractional Flow Reserve Derived From Computed Tomography Angiography: Insight From the SYNTAX III Trial (2019) (1)
- The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience (2022) (1)
- TCT-221 Treatment Recommendations Based on SYNTAX Score II and Observed 3-year Mortality in the EXCEL Trial (2017) (1)
- TCT-111 Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for Three Vessel Disease (2019) (1)
- HIGH SPEED INTRA-CORONARY OPTICAL FREQUENCY DOMAIN IMAGING: IMPLICATIONS FOR THREE-DIMENSIONAL RECONSTRUCTION AND QUANTITATIVE ANALYSIS (2011) (1)
- Site vs. core laboratory variability in computed tomographic angiography-derived SYNTAX scores in the SYNTAX III trial. (2020) (1)
- Corrigendum to "Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model" [Int. J. Cardiol. 227 (2017) 467-473]. (2017) (1)
- 1-Year Patency of Biorestorative Polymeric Coronary Artery Bypass Grafts in an Ovine Model (2022) (1)
- Impact of the CABG SYNTAX Score on 10-year All-cause Death: Insights from the SYNTAX Extended Survival Study. (2020) (1)
- TCTAP A-072 Immediate Effect of Percutaneous Coronary Intervention by Bioresorbable Scaffold or Drug-Eluting Stent on Superficial Wall Strain of Stenotic Coronary Arteries (2022) (1)
- Progression of calcification after implantation of a fully bioresorbable scaffold: A serial and combined IVUS-OCT follow-up of 5years. (2016) (1)
- INTRACORONARY OPTICAL COHERENCE TOMOGRAPHY (OCT) AND HISTOLOGY 2, 3 AND 4 YEARS AFTER IMPLANTATION OF BIORESORBABLE EVEROLIMUS-ELUTING STENTS IN A PORCINE CORONARY MODEL: AN ATTEMPT TO DECIPHER THE HUMAN OCT IMAGES IN THE ABSORB TRIAL (2010) (1)
- Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial (2022) (1)
- External validation of the GRACE risk score 2.0 in the contemporary all‐comers GLOBAL LEADERS trial (2021) (1)
- TCT-765 Effect of PSP and other Elements of Technique on 3 Year Outcomes Among Metallic Everolimus-Eluting Stent-Treated Patients in the ABSORB Trials (2018) (1)
- TCT-116 Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization (2021) (1)
- LBT-6 Two-years Clinical Outcomes Of The ABSORB BVS Compared EES: A Propensity Matched Analysis Of The BVS Expand Registry (2017) (1)
- Successful Reperfusion with a Percutaneous Aspiration Thrombectomy Device, TVAC^ , in a Case of Acute Inferior Myocardial Infarction due to Occlusion of the Distal Segment of the Dilated Right Coronary Artery (2005) (1)
- Multimodality Imaging to Detect Vulnerable Plaque in Coronary Arteries and Its Clinical Application (2017) (1)
- DIFFERENCES IN THE OCCURRENCE OF NEW OR WORSENING ANGINA BETWEEN THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND XIENCE METALLIC STENT: A POST-HOC ANALYSIS OF THE ABSORB II RANDOMIZED TRIAL (2015) (1)
- Was the Ball Inside or Outside the Court?: Ask the Hawk-Eye System. (2019) (1)
- A prospective multicentre randomized all-comers trial to assess the safety and effectiveness of the ultra-thin-strut sirolimus-eluting coronary stent Supraflex: 2-year results of the TALENT trial (2020) (1)
- Comparative Quantitative Aortographic Assessment of Regurgitation in Patients Treated With VitaFlow Transcatheter Heart Valve vs. Other Self-Expanding Systems (2022) (1)
- LONG-TERM TICAGRELOR MONOTHERAPY IN ELDERLY PATIENTS UNDERGOING PCI IN THE GLOBAL LEADERS STUDY (2019) (1)
- Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy. (2022) (1)
- Imaging and 2‐year clinical outcomes of thin strut sirolimus‐eluting bioresorbable vascular scaffold: The MeRes‐1 extend trial (2020) (1)
- Abstract 4374: Persistent Conduction Abnormalities and Requirements for Pacemaking 6 Months After Transcatheter Aortic Valve Implantation (2009) (1)
- Unlocking scaffold mechanical properties (2017) (1)
- CRT-100.33 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) in Brazil and Japan: Synergy Stent with Prasugrel Monotherapy Without Aspirin (2023) (1)
- Reply: Percutaneous Revascularization of Left Main Disease: Could the Angiographic Follow-Up Improve the Survival? (2017) (1)
- Transferability of data between different drug-eluting stents. (2009) (1)
- Two years clinical outcomes with the state‐of‐the‐art PCI for the treatment of bifurcation lesions: A sub‐analysis of the SYNTAX II study (2020) (1)
- RELATION BETWEEN BIORESORBABLE SCAFFOLD SIZING USING QCA-DMAX AND CLINICAL OUTCOMES AT 2 YEARS IN 1192 PATIENTS FROM THREE STUDY COHORTS (ABSORB COHORT B, ABSORB EXTEND AND ABSORB II) (2016) (1)
- Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial / Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypas (1)
- Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease. (2021) (1)
- TCT-507 Edge Vascular Response After Resorption of Everolimus-Eluting Bioresorbable Vascular Scaffold: A 5-Year Serial Optical Coherence Tomography Study (2015) (1)
- TCT-309 Angiography-derived fractional flow reserve in the SYNTAX II trial: diagnostic accuracy of QFR and clinical prognostic value of functional SYNTAX score derived from QFR (2018) (1)
- TCT-245 Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials (2014) (1)
- Coronary interventions 2020: the year in review. (2021) (1)
- TCT-302 Optical Coherence Tomography–Derived Changes in Plaque Structural Stress Over the Cardiac Cycle: A New Method for Plaque Biomechanical Assessment (2021) (1)
- The effect of strut thickness on shear stress distribution in a preclinical model (2017) (1)
- Short- and Long-term Evaluation of Bioresorbable Scaffolds by Optical Coherence Tomography. (2015) (1)
- Interventional Cardiology Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents A Prospective Cohort Study (2012) (1)
- TCT-431 RANDOMIZED COMPARISON OF ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND MIRAGE MICROFIBER SIROLIMUS ELUTING SCAFFOLD USING MULTI-MODALITY IMAGING. (2016) (1)
- LONG-TERM SAFETY OF TICAGRELOR MONOTHERAPY IN PATIENTS UNDERGOING PCI FOR STABLE CORONARY ARTERY DISEASE IN THE GLOBAL LEADERS STUDY: IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2019) (1)
- A randomized controlled trial to compare the safety and efficacy of sirolimus-eluting biodegradable polymer ultra-thin stent (SUPRAFLEX Cruz) and everolimus-eluting biodegradable polymer stent (SYNERGY) in treatment for three-vessel coronary artery disease: design of the Multivessel TALENT trial. (2020) (1)
- ACUTE RECOIL FOLLOWING IMPLANTATION OF EVEROLIMUS-ELUTING ABSORB BIODEGRADABLE VASCULAR SCAFFOLDS OR XIENCE METALLIC STENTS: THE ABSORB II TRIAL (2015) (1)
- Clinical practice and ethics vs. statistics: considerations on Heart Team's decision testing study. (2019) (1)
- TCT-491 Incidence of Peri-Procedural Myocardial Infarction after Bifurcation Percutaneous Coronary Intervention According to Different Definitions: Insight from the Tryton IDE randomized trial (2015) (1)
- AS-067 Endothelial-Dependent Vasomotion in Coronary Segment Treated by ABSORB Everolimus-Eluting Bioresorbable Vascular Scaffold System is Related to Plaque Composition at the Time of Bioresorption of the Polymer: Indirect Finding of Vascular Reparative Therapy? (2012) (1)
- Editorial: Computational modeling for assessing coronary artery pathophysiology (2023) (1)
- Acute myocardial infarction due to spontaneous coronary artery dissection detected three days before by 64-slice spiral computed tomography. (2006) (1)
- Novel bioresorbable scaffolds technologies: current status and future directions. (2015) (1)
- Usability of Fantom Encore® scaffold in non‐complex bifurcations–Analysis in bench models (2021) (1)
- Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study. (2019) (1)
- Quantitative coronary angiography of bioresorbable vascular scaffold: A core lab perspective (2017) (1)
- Likelihood reclassification by an acoustic-based score in suspected coronary artery disease (2023) (1)
- A prospective multicenter randomized trial to assess the effectiveness of the magic touch sirolimus-coated balloon in small vessels: Rationale and design of the TRANSFORM I trial. (2020) (1)
- Coronary Stent Technology (2010) (1)
- Serial Optical Coherence Tomography at Baseline, 7 Days, and 1, 3, 6 and 12 Months After Bioresorbable Scaffold Implantation in a Growing Porcine Model. (2019) (1)
- CRT-148 A Study Of Conformability in Everolimus-eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents in Long Lesions (2015) (1)
- TCT-172 Hemodynamic Analysis of New Version Mirage Bioresorbable Scaffold and Metallic Ultimaster Stent: A New Era Begins With Shear Stress Analysis in Stent Assessment (2019) (1)
- EuroIntervention: at the crossroads of open access. (2018) (1)
- Plaque burden estimated from optical coherence tomography with deep learning: In vivo validation using co‐registered intravascular ultrasound (2022) (1)
- Coronary bioresorbable vascular scaffold radiopaque marker embolization. (2017) (1)
- The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy (2020) (1)
- Abstract 6003: The Unrestricted Use of Everolimus-Eluting Stents for De-novo coronary lesions: The Xience V Stent Evaluated At Rotterdam Cardiology Hospital (X-SEARCH) Registry (2008) (0)
- TCTAP A-028 Predicted and Observed Mortality at 10-Year in Patients With Bifurcation Lesion in the SYNTAX Trial (2022) (0)
- TCT-83 A Comparison Between CEC-Based and QFR-Based Adjudication Among 3,457 Patients From 4 Randomized Controlled Trials (2021) (0)
- P6374Acute and long-term relocation of minimal lumen area after Absorb bioresorbable scaffold or Xience metallic stent implantation (2018) (0)
- TCT CONNECT-271 The MeRes-1 Extend Trial: 2-Year Clinical and 6-Month Imaging Outcomes of Thin-Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions (2020) (0)
- Intravascular Ultrasound and Optical Coherent Tomography Combined Catheter. (2023) (0)
- TCT-279 Impact of Body Composition Indices on Ten-Year Mortality After Revascularization of Complex Coronary Artery Disease (From the Syntax Extended Survival Trial) (2021) (0)
- CRT-600.09 Comparison of the SYNTAX Score 2020 Based on Coronary Artery Computed Tomography or Invasive Coronary Angiography (2023) (0)
- Emerging technologies: Overview of the field (2017) (0)
- TCT-675 Site versus Core Laboratory SYNTAX score variability (2018) (0)
- Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease. (2022) (0)
- Histological Changes in Skin Tissues and Tissue Mast Cells of Rats after Irradiation of Ultrasoft Rays and the Effect of Pretreatment of Cysteine or Glutathione on Them. (1961) (0)
- TCT-148 Murray’s Law–Based Quantitative Flow Ratio for Assessment of Left Main Bifurcation Derived From a Single Fluoroscopic Angiographic View Compared With FFRCT (2022) (0)
- Ex-vivo and In-vivo Validation of Novel Quantitative Videodensitometric Assessment of Mitral Regurgitation Following Surgical Mitral Valve Replacement (2021) (0)
- The Dual Antiplatelet Therapy study at the American Heart Association meeting: an issue that concerns all of us. Future changes in the paradigm or a look into the past? (2014) (0)
- TCT-446 Feasibility study of a single synchronized diastolic injection with low contrast volume for aortography in a progressive aortic regurgitation porcine model. (2018) (0)
- TCT-67 Impact of the SYNTAX score in patients with diabetes and left-main and/or multivessel coronary disease: a pooled analysis of individual patient level data from the SYNTAX, PRECOMBAT and BEST trials. (2016) (0)
- A comparison of risk prediction models for patients with acute coronary syndromes. (2021) (0)
- TCTAP A-083 Quantitative Angiographic Assessment of Aortic Regurgitation Post 11 Different Types of TAVR Devices (A MulticentER Pooled Analysis of 2665 Valves) (2022) (0)
- Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent. (2020) (0)
- Abstract 3426: Impact of Culprit Plaque Composition on No-Reflow Phenomenon in Patients with Acute Coronary Syndrome: an Intravascular Ultrasound Radiofrequency Analysis (2006) (0)
- The Everolimus-Eluting Stent in Real-World Patients Six-Month Follow-Up of the Xience V Stent Evaluated at Rotterdam Cardiac Hospital (X-SEARCH) Registry (2009) (0)
- Department of Error (2021) (0)
- IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER DAPT (2023) (0)
- TCT-443 Quantitative assessment of aortic regurgitation in 7 different types of aortic valves after transcatheter aortic valve implantation: a multicenter analysis by an independent core lab not sponsored by the industry (2018) (0)
- TCT-193 The Effect of Plaque Type on Strut Embedment/Protrusion and Shear Stress in Bioresorbable Scaffold: Is There a New Horizon For Bioresorbable Scaffolds? (2018) (0)
- TCTAP A-064 The Impact of Plaque Type on Strut Embedment/Protrusion and Shear Stress Distribution in Bioresorbable Scaffold (2019) (0)
- TCT-674 Impact of coronary calcification on the agreement between coronary CTA and conventional angiography in the SYNTAX score treatment decision (2018) (0)
- Quantitative assessment of prosthetic valve regurgitation after TAVI by angiography and cardiac magnetic resonance imaging (2017) (0)
- Acute scaffold disruption and late discontinuities (2017) (0)
- P2398Coronary calcification as a mechanism of plaque media shrinkage a multimodality intracoronary imaging study (2017) (0)
- PE-219 Direct Infusion of Nicorandil Distal to Infarct Related Artery Prior to Reperfusion in Patients with Acute Myocardial Infarction.(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 12 (IHD) : PE38)(Poster Session (English)) (2004) (0)
- CRT-101.04 An Assessment of the Leaman Score Inter-Observer Reproducibility in an Independent Core Lab (2023) (0)
- TCTAP A-043 Precise Assessments of Dissection Following Drug-Coated Balloon Treatment and Its Impact on Clinical Outcomes in de Novo Small Vessel Disease (2023) (0)
- TCT-176 Diagnostic Accuracy of Coronary Computed Tomography Angiography for the Evaluation of Bioresorbable Vascular Scaffolds (2017) (0)
- TCT-421 Predicting 2 Years All-Cause Mortality After Contemporary PCI: Revising and Updating the Logistic Clinical SYNTAX Score in the GLOBAL LEADERS Study (2019) (0)
- CRT-100.07 Feasibility and Accuracy of Holographic Graft Length Measurement, a Sub-study of the FAST TRACK CABG Trial (2023) (0)
- Impact of coronary calcification assessed by coronary CT angiography on treatment decision in patients with three-vessel CAD: insights from SYNTAX III trial (2021) (0)
- Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization (2022) (0)
- Abstract 1147: Drug Eluting Stents Do Not Delay Early Endothelialization But Show Distinct Differences In Endothelial Function (2008) (0)
- TCT-101 Machine Learning–Based Prediction of Long-Term Mortality After Percutaneous and Surgical Revascularization in Patients With Complex Coronary Artery Disease: Analysis of the Multicenter Randomized Controlled SYNTAXES Trial With External Cohort Validation (2022) (0)
- TCTAP A-084 Lesion-Specific Myocardial Mass: A New Index for Diagnosis and Treatment of Coronary Artery Disease (2015) (0)
- 126Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy (2019) (0)
- FATE OF SIDE BRANCHES AT 6 AND 12 MONTHS AFTER IMPLANTATION OF BIORESORBABLE VASCULAR SCAFFOLDING DEVICES: ASSESSMENT WITH 3-DIMENSIONAL OPTICAL COHERENCE TOMOGRAPHY (2011) (0)
- THE ROLE OF QUANTITATIVE AORTOGRAPHIC ASSESSMENT OF AORTIC REGURGITATION IN THE GUIDANCE OF TRANSCATHETER AORTIC VALVE IMPLANTATION (2018) (0)
- TCT-444 Comparison of transthoracic echocardiogram with quantitative assessment of aortic regurgitation after TAVI with videodensitometry in a large real-world population: sub-analysis of the RESPOND registry. (2018) (0)
- TCT-676 Could the logistic clinical SYNTAX score have predicted the all-cause mortality in the Global Leaders trial? A prediction prior to the unblinding of the trial (2018) (0)
- TCT-60 The Impact of Implantation Techniques in Absorb BVS and Xience EES on Lesion-Oriented Outcomes at Complete 5-Year Follow-Up—An AIDA Trial QCA Substudy (2022) (0)
- Abstract 5614: Primary Percutaneous Coronary Intervention For Acute Myocardial Infarction: Long-term Outcome Following Bare Metal And Drug-eluting Stent Implantation (2008) (0)
- TCT-201 Impact of Proton Pump Inhibitors on Efficacy of Antiplatelet Strategies With Ticagrelor or Aspirin After Percutaneous Coronary Intervention (2021) (0)
- Impact of periprocedural myocardial infarction on 10-year mortality after percutaneous coronary intervention or coronary artery bypass grafting for multivessel or left main coronary artery disease (2020) (0)
- TCT-322 Agreement between coronary CTA and conventional angiography on the SYNTAX score tertiles stratified by anatomical complexity in the SYNTAX III Revolution trial (2018) (0)
- Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre (2021) (0)
- Calcified plaque detected on OCT with deep learning and cross-validated with optical and ultrasound signals: A complementary appraisal and preamble to combined IVUS-OCT catheter (2022) (0)
- CRT-400.00 Long-term Multislice Computed Tomography Coronary Angiography (CTCA) RESULTS For Bioresorbable Vascular Scaffold (BVS) In Clinical Practice. A BVS-Expand Project (2017) (0)
- TCT-64 Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial (2018) (0)
- TCT-398 Impact of Long-Term Ticagrelor Monotherapy Following 1-Month Dual Antiplatelet Therapy in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insights From the Global Leaders Trial (2019) (0)
- Serial Assessment of Tissue Precursors and Progression of Coronary Calci fi cation Analyzed by Fusion of IVUS and OCT 5-Year Follow-Up (2017) (0)
- TCT-104 Impact of Left Ventricular Ejection Fraction (EF) on 10-Year Mortality After Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG): Is CABG Safer Than PCI in All Patients With Reduced EF? (2022) (0)
- Discordance between Invasive and Non-Invasive Coronary Angiography: An In-Depth Functional and Anatomical Analysis (2023) (0)
- Reply (2018) (0)
- TCTAP A-026 Impact of Geographic Disparity on 10-Year Mortality in the SYNTAXES Trial, According to the SYNTAX Score II 2020 and Applying Machine Learning (Gradient Boosting Model) (2022) (0)
- Computed tomographic angiography in coronary artery disease. (2023) (0)
- TCT-304 Ten-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification (2021) (0)
- TCT-805 Angina frequency and quality of life after implantation of bioresorbable scaffold implantation in complex lesions (2017) (0)
- TCTAP A-035 Fractional Flow Reserve in Left Main Bifurcation From a Single Fluoroscopic View Versus Computed Tomography (2023) (0)
- 93. Hormonal Changes and Female Pelvic Development in Puberty (1978) (0)
- Letter to the editor in response to Kobo et al. 2022 (2022) (0)
- TCT-159 Endothelial Shear Stress and Local Viscosity Assessment of Coronary Bioresorbable Scaffold: A Five-Year Follow Up (2018) (0)
- CRT-100.06 Impact of Left Ventricular Ejection Fraction on 10-Year Mortality After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting: Is CABG Safer Than PCI in All Patients With Reduced Ejection Fraction? (2023) (0)
- TCT-473 Impact of Major Infections on 10-Year Mortality After Revascularization in Patients With Complex Coronary Artery Disease (2021) (0)
- Valvular heart interventions: advances from 2019 to 2020. (2020) (0)
- TCT-529 Incidence of persistent, resolved, and late incomplete scaffold apposition after bioresorbable scaffold implantation in ST-segment elevation myocardial infarction. A BVS-STEMI-first substudy (2015) (0)
- TCT-170 Impact of rate of recruitment on all-cause mortality: Insights from the GLOBAL LEADERS all-comers trial (2018) (0)
- PE-102 Impact of 64-slice Multidetector Computed Tomography on the Outcome of Percutaneous Coronary Intervention(CT/DSA-3 (I) PE17,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
- TCT-36 Circumferential distribution of the neointima tissue at 6 months and 2 at years follow-up after a bioresorbable scaffold implantation. A serial optical coherence tomography study (2012) (0)
- Interventional cardiology: review of the year 2017. (2018) (0)
- In the Beginning There Was Angina Pectoris, at the End There Was Still Angina Pectoris. (2022) (0)
- STRUT PROTRUSION DISTANCE AND SHAPE IMPACT ON ENDOTHELIAL SHEAR STRESS: INSIGHTS FROM PRE-CLINICAL STUDY COMPARING MIRAGE AND ABSORB BIORESORBABLE SCAFFOLDS IN PORCINE CORONARY MODEL (2017) (0)
- Ten-year all-cause death after percutaneous or surgical revascularization for men and women with multivessel or left main coronary artery disease: insights from the SYNTAX extended survival study (2020) (0)
- TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials. (2016) (0)
- TCT-438 Outcomes After Bailout Stenting with Absorb BVS or XIENCE: Meta-analysis of Randomized Trials. (2016) (0)
- Reduced-dose prasugrel monotherapy without aspirin after PCI with the SYNERGY stent in East Asian patients presenting with chronic coronary syndromes or non-ST-elevation acute coronary syndromes: rationale and design of the ASET Japan pilot study. (2023) (0)
- TCT-642 PARIS Risk Score Stratified Analysis of Clinical Outcomes Among Elderly Patients (Aged > 75 Years) Treated With 23-Month Ticagrelor Monotherapy Following 1-Month DAPT After PCI in the GLOBAL LEADERS Trial (2019) (0)
- Guide Catheter Delamination During Left Main Stenting After Transcatheter Aortic Valve Replacement. (2020) (0)
- What are appropriate clinical endpoints? From device failure assessment to angina evaluation (2017) (0)
- CLINICAL OUTCOMES AT 2 YEARS OF THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD VERSUS THE XIENCE DRUG-ELUTING METALLIC STENT IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME VERSUS STABLE CORONARY DISEASE: AIDA TRIAL SUB-STUDY (2019) (0)
- 462 Comparison Of The Syntax Score 2020 Based On Coronary Artery Computed Tomography (CCTA) With Invasive Coronary Angiography (ICA) (2022) (0)
- TCTAP A-032 One Year Patency of Biorestorative Polymeric Coronary Artery Bypass Grafts in an Ovine Model: Serial Assessment of Quantitative Coronary Angiography and Flow Ratio (2022) (0)
- Alternative stents in ST-segment elevation myocardial infarction: improving the efficacy of primary percutaneous coronary intervention. (2015) (0)
- Abstract 4549: Clopidogrel Discontinuation and Long-term Outcome After Percutaneous Coronary Intervention (2009) (0)
- P5629The effect of strut protrusion on local shear stress and neointimal hyperplasia (2019) (0)
- 1969Computed Tomography Coronary Angiography Long-term Results of Bioresorbable Vascular Scaffold in clinical practice. A BVS-Expand project (2017) (0)
- TCT-369 Correlation of Cardiovascular Risk Factors, Angina Patterns and Intravascular Ultrasound Findings: Largest Contemporary Characterization of Target Lesions (2015) (0)
- Noninvasive coronary computed tomography analysis after bioresorbable scaffold implantation (2017) (0)
- TCTAP A-050 Calcified Plaque Detected on Optical Coherence Tomography With Deep Learning and Cross-Validated With Optical and Ultrasonic Signals: A Complementary Appraisal and Preamble to the Use of Combined IVUS-OCT Catheter (2022) (0)
- Reply: Predictors of Bioresorbable Everolimus-Eluting Scaffold Failure at Intravascular Ultrasound Examination: Asymmetry Versus Expansion. (2016) (0)
- Will coronary artery bypass grafting remain a standard of care for elderly patients with multivessel disease in the contemporary era? (2020) (0)
- Mid- to Long-Term Clinical Outcomes of€Patients Treated With the Everolimus-Eluting Bioresorbable Vascular€Scaffold (0)
- Reply: Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease. (2017) (0)
- Letter by Garcia-Garcia et al regarding article, "Impact of frequency-domain optical coherence tomography guidance for optimal coronary stent implantation in comparison with intravascular ultrasound guidance". (2012) (0)
- TCT-445 Feasibility of analysis of a novel quantitative method to assess aortic regurgitation after TAVI: Preliminary results of the ASSESS-REGURGE Protocoled Quantitative ASSESSment of aortic regurgitation using Videodensitometry in a multicenter study in Rotterdam, montrEal, yamaGUchi, segebeRG, a (2018) (0)
- INCIDENCE AND POTENTIAL MECHANISM(S) OF POST-PROCEDURAL RISE OF CARDIAC BIOMARKERS IN THE RANDOMIZED ABSORB II TRIAL COMPARING AN ABSORB SCAFFOLD AND A XIENCE STENT. (2015) (0)
- TCT-362 Checking the reality of the SYNTAX III Revolution trial: Comparison of the virtual heart team decision with the treatment executed (2018) (0)
- TCTAP A-039 On-Pump and Off-Pump Coronary Artery Bypass Grafting on 10-Year Mortality Versus Percutaneous Coronary Intervention (2023) (0)
- Are We Unisex When Undergoing Left Main Revascularization? (2022) (0)
- Predicted Risk of Adverse Clinical Outcomes According to Renal Function. (2014) (0)
- IMPACT OF CORONARY REMODELING ON CORONARY PHYSIOLOGY: A SERIAL CORONARY COMPUTED TOMOGRAPHY STUDY (2018) (0)
- A MEDIUM TERM FOLLOW-UP BY MULTISLICE COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY ASSESSING THE PERSISTENT PRESENCE OF BIORESORBABLE VASCULAR SCAFFOLD METALLIC RADIOPAQUE MARKERS AT THE SITE OF IMPLANTATION (2015) (0)
- TCTAP A-073 Murray Law-Based Quantitative Flow Ratio for Assessment of Left Main Bifurcation Derived From a Single Fluoroscopic Angiographic View as Compared to FFRCT (2022) (0)
- Department of Error (2021) (0)
- TCT@ACC–i2: Invasive and Interventional Cardiology ADDITIONAL SIDE BRANCH STENT PLACEMENT IN PATIENTS WITH LONG SIDE BRANCH LESIONS TREATED WITH A DEDICATED TRYTON SIDE BRANCH STENT (2013) (0)
- LONG TERM IMPACT OF PROXIMAL LEFT ANTERIOR DESCENDING ARTERY LESIONS IN PATIENTS WITH THREE-VESSEL AND/OR LEFT-MAIN CORONARY ARTERY DISEASE: A PATIENT-LEVEL POOLED ANALYSIS OF 3280 PATIENTS FROM THE SYNTAX, PRECOMBAT AND BEST TRIALS (2016) (0)
- Optical coherence tomography analysis of bioresorbable vascular scaffolds in comparison with metallic stents: A core lab perspective (2017) (0)
- TCT-552 SERIAL ASSESSMENT OF CALCIFICATION 5 YEARS AFTER BIORESORBABLE VASCULAR SCAFFOLD IMPLANTATION: FUSION OF INTRAVASCULAR ULTRASOUND AND OPTICAL COHERENCE TOMOGRAPHY. (2016) (0)
- Ten-year all-cause death in elderly patients undergoing percutaneous coronary intervention or coronary artery bypass grafting: a prespecified subgroup analysis of the SYNTAX Extended Survival study (2020) (0)
- Cobalt-Chromium Everolimus-Eluting Stents (2016) (0)
- TCT-137 Contribution of Plaque Composition to the Extent of Plaque Fracture and Dissection Following Drug-Coated Balloon Angioplasty in De Novo Small Vessel Disease: An Interim Report of the TRANSFORM-I Trial (2022) (0)
- TCT-457 The use of a dedicated coronary bifurcation stent in patients presenting with myocardial infarction (2012) (0)
- TCTAP A-030 Ten Years Survival Benefit and Appropriateness of Surgical or Percutaneous Revascularization Based on Individual Predicted All-Cause Mortality in Patients With Complex Coronary Artery Disease (2022) (0)
- FUSION OF INTRAVASCULAR ULTRASOUND AND OPTICAL COHERENCE TOMOGRAPHY IMAGINGS TO COMPREHENSIVELY ASSESS CALCIFIED PLAQUE DEVELOPMENT IN- AND OUT-SCAFFOLD SEGMENTS AFTER BIORESORBABLE ABSORB SCAFFOLD IMPLANTATION (2016) (0)
- Ten-year all-cause mortality following staged percutaneous revascularization in patients with complex coronary artery disease. (2021) (0)
- TCT-593 In Vivo Assessment of the Bioresorption process of Everolimus-eluting PLLA Scaffold: a Light Intensity Analysis of Sequential Optical Coherence Tomography Imaging post Procedure, and at 1 and 3 Years in The ABSORB Cohort B2 Trial (2013) (0)
- Abstract 6005: Six Month Clinical Outcome Following the Use of Everolimus-eluting Stents for ST-segment Elevation Myocardial Infarction: Insights from the Xience V Stent Evaluated At Rotterdam Cardiology Hospital (X-SEARCH) Registry (2008) (0)
- TCT-112 Patient-oriented clinical outcomes and net adverse cardiovascular event in the Global Leaders trial (2018) (0)
- TCT-388 Impact of main branch selection on clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery disease: a substudy from the DELTA registry. (2013) (0)
- What have we learned from meta-analysis of 1-year outcomes with the ABSORB bioresorbable scaffold in patients with coronary artery disease? (2017) (0)
- CRT-100.03 Pre- and Post-Percutaneous Coronary Intervention Quantitative Flow Ratio: An Analysis and Tentative Prediction of 2-Year Vessel-Oriented Composite Events in the MULTIVESSEL TALENT Trial (2023) (0)
- TCT-12 Clinical, Angiographic and Procedural Correlates of Very Late Absorb Scaffold Thrombosis – Multi-Study Registry Results (2017) (0)
- TCT-404 Benefit and Risks of Aspirin on Top of Ticagrelor in Acute Coronary Syndromes: Insights From the Randomized GLOBAL LEADERS Trial (2019) (0)
- Polylactide Bioresorbable Scaffolds: From inception to long-term follow-up of first in man studies (2014) (0)
- 水素化エポキシ樹脂、その製造方法、エポキシ樹脂組成物及び発光素子封止材用エポキシ樹脂組成物 (2005) (0)
- TCTAP A-077 Two-year Imaging Results of the Absorb Bioresorbable Everolimus Eluting Vascular Scaffold with Planned Overlapping from the ABSORB EXTEND Optical Coherence Tomography Subgroup (2015) (0)
- CRT-100.17 Assessment of Reasons for Sub-Optimal Results After Percutaneous Coronary Intervention Using Ultrasonic Flow Ratio (UFR): Insights From MULTIVESSEL TALENT Trial (2023) (0)
- Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN). (2023) (0)
- TCT-344 Abstract Withdrawn (2015) (0)
- THE IMPACT OF BODY MASS INDEX ON THE ONE YEAR OUTCOME OF PATIENTS TREATED BY PCI WITH BIOLIMUS- AND SIROLIMUS- ELUTING STENTS FROM THE LEADERS TRIAL. (2010) (0)
- CRT-100.19 Fractional Flow Reserve in Left Main Bifurcation From a Single Fluoroscopic View Versus Computed Tomography (2023) (0)
- Response to the Reviewers Reviewer 1 : Dr (2013) (0)
- CRT-600.05 Precise Assessments of Dissection Following Drug-Coated Balloon Treatment and Its Impact on Clinical Outcomes in De Novo Small Vessel Disease (2023) (0)
- TCT-787 High-Sensitive Cardiac Troponin Predicts 2-years Mortality in Patients with Coronary Artery Disease- subanalysis of the GLOBAL LEADERS trial (2018) (0)
- OE-118 Efficacy of 64-slice Multidetector Computed Tomography in Diabetic Patients with Suspected Coronary Artery Disease(CT/DSA-01, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
- TCT-564 Implications of the local hemodynamic forces on vessel wall responses following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography analysis (2013) (0)
- CORONARY ARTERY DISEASE Original Studies Predictors of Long-Term Outcomes after Bypass Grafting Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease (2017) (0)
- THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W– DELTA (WOMEN– DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY (2013) (0)
- CORONARY CALCIFICATION AS A MECHANISM OF PLAQUE/MEDIA SHRINKAGE: A MULTIMODALITY INTRACORONARY IMAGING STUDY (2017) (0)
- Syntax II and Syntax III trials: what is the take home message for surgeons? The Syntax III trial (2018) (0)
- TCT-113 Ten-Year Survival Benefit and Appropriateness of Surgical or Percutaneous Revascularization Based on Individual Predicted All-Cause Mortality in Patients With Complex Coronary Artery Disease (2021) (0)
- TCT-430 In vitro and preclinical evaluation of a thin-strut bioresorbable scaffold: results from bench testing and acute phase study in a non-atherosclerotic porcine model. (2018) (0)
- Acute and chronic exercise training in patients with Class II pulmonary hypertension: effects on haemodynamics and symptoms (2022) (0)
- TCT-260 Comparison of the SYNTAX Score 2020 Based on Coronary Artery Computed Tomography (CCTA) or Invasive Coronary Angiography (ICA) (2022) (0)
- TCT-391 Post-implantation Shear Stress Analysis: An Emerging Tool for Differentiation in Bioresorbable Scaffolds (2018) (0)
- TCT-435 Validation of In Vivo Prosthetic Mitral Regurgitation Quantification Using a Novel Videodensitometric Angiographic Platform by In Vitro Mock Circulation (2021) (0)
- CRT-100.08 Can a Machine Learning-Based Approach Improve Risk Prediction and Individualise Decision Making Between Percutaneous and Surgical Revascularisation in Patients With Complex Coronary Artery Disease? (2023) (0)
- TCT-671 The Role of Pre-existing Aortic Regurgitation on The Clinical Impact of Aortic Regurgitation after Transcatheter Aortic Valve Implantation. (2016) (0)
- TCT-592 Incidence, imaging and clinical outcomes of acute scaffold disruption and late structural discontinuity after implantation of the Absorb everolimus-eluting fully bioresorbable vascular scaffold: Optical coherence tomography assessment in the ABSORB Cohort B trial (2013) (0)
- System implantation with the 18 F CoreValve ReValving patients undergoing transcatheter aortic valve Adherence to patient selection criteria in (2009) (0)
- TCT-492 External Validation of the SYNTAX Score II 2020 in the CREDO-Kyoto PCI/CABG Registry (2021) (0)
- TCT-57 Impact of Lesion Length on 1-year Outcomes of Absorb Bioresorbable Vascular Scaffolds. (2016) (0)
- Treatment of complex coronary artery disease in patients with diabetes mellitus and chronic kidney disease: 10-year results comparing outcomes of CABG and PCI in the SYNTAXES trial (2020) (0)
- CRT-400.02 Anonymous Comparative Assessment by an Academic Core Laboratory of Four Angiography-Derived Fractional Flow Ratio Software in Patients With Pressure Derived iFR and FFR (2023) (0)
- PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY (2019) (0)
- Abstract 3038: Long-term Outcomes After Treatment Of In-stent Restenosis With Bare-metal Stent And Drug-eluting Stent: Insights From Research And T-search Registry (2008) (0)
- TCT-13 Ten-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease (2021) (0)
- TCT-343 Post-procedural geometrical parameters and their impact on adverse cardiovascular events: insights from the ABSORB II trial (2015) (0)
- Reply: Following Renal Outcomes With Staging in Percutaneous Coronary Intervention Trials. (2018) (0)
- Left Main Coronary Artery Embolism after Transcatheter Aortic Valve Replacement: Insights from Multimodal Intracoronary Imagings (2018) (0)
- TCT-368 Preclinical validation of light intensity analysis on Optical Coherence tomography to monitor bioresorption and integration process after implantation of a bioresorbable scaffold in porcine model: a comparison between OCT and Histology (2014) (0)
- TCT-385 The MADS Classification in Patients Undergoing Left Main Percutaneous Coronary Intervention: Technique Analysis From the IDEAL LM Trial (2019) (0)
- INTERVENT IONS FOR VALVULAR D ISEASE AND HEART FA ILURE (2016) (0)
- Biorestorative Valve for Transcatheter Aortic Valve Implantation: Tomorrow’s World from Preclinical to Clinical (2019) (0)
- Abstract 4925: Noninvasive Angiographic Follow-Up 18 Months after Bioabsorbable Everolimus-Eluting Stent Implantation Using 64-Slice Computed Tomography (ABSORB) (2008) (0)
- CRT-100.97 What Did I Learn in the 10 Years of SYNTAX? – Closing an Era of Clinical Research After Having Identified New Trial Targets With Machine Learning? (2023) (0)
- TCT-415 Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women? (2016) (0)
- Can machine learning unravel unsuspected, clinically important factors predictive of long-term mortality in complex coronary artery disease? A call for “Big Data” (2023) (0)
- The Mirage microfiber sirolimus eluting coronary scaffold (2017) (0)
- The incidence and potential mechanism of side-branch occlusion after implantation of bioresorbable scaffolds: Insights from ABSORB II (2017) (0)
- 058 THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W-DELTA (WOMEN-DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY (2013) (0)
- Abstract 17174: Predictors of Stent Thrombosis after Everolimus-Eluting and Paclitaxel-Eluting Stents: The Pooled SPIRIT Randomized Trial Experience at Two Years of Follow-Up (2010) (0)
- TCTAP A-024 Hemodynamic Analysis of New Version Mirage Bioresorbable Scaffold and Metallic Ultimaster Stent: A New Era Begins With Shear Stress Analysis in Stent Assessment (2022) (0)
- Abstract 14062: The Unrestricted Use of Sirolimus- and Paclitaxel-Eluting Stents Results in Better Clinical Outcomes During 6-Years Follow-up than Bare-Metal Stents. An analysis of the RESEARCH and T-SEARCH registries. (2010) (0)
- Reply to the letter to the editor "Stenosis severity indices cannot reflect lumen loss in stent trials". (2018) (0)
- TCT-254 Everolimus Eluting Bioresorbable Vascular Scaffolds In Patients With ST-Segment Myocardial Infarction. Safety Feasibility and Acute Performance (2013) (0)
- The prevalence and clinical consequences of intimal flaps detected by optical frequency domain imaging in the proximal segments of coronary arteries (2013) (0)
- Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study (2020) (0)
- Abstract 4346: One-year Outcomes After Implantation of Everolimus-eluting for Diabetic Patients With de-Novo Coronary Artery Stenoses: Insights From RESEARCH, T-SEARCH and X-SEARCH Registries (2009) (0)
- CRT-700.12 BVS-DAPT: Pooled Data Of Three Dutch Regional Registries To Invest The Impact Of Dapt Termination On Late And Very Late Scaffold Thrombosis (2017) (0)
- 500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study. (2019) (0)
- PE-322 Prevalence and Clinical Impact of Non-calcified Plaques in Patients with a Negative Calcium Score Study(CT/DSA-07, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
- INTER-CORE LAB VARIABILITY IN ANALYZING QUANTITATIVE CORONARY ANGIOGRAPHY FOR BIFURCATION LESIONS: A POST-HOC ANALYSIS OF A RANDOMIZED TRIAL (2015) (0)
- PROGNOSTIC IMPLICATIONS OF SEVERE LESION CALCIFICATION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (2014) (0)
- Prevalence of Carotid Artery Stenosis in Patients with Coronary Artery Disease in Japan(Peripheral Circulation/Vascular Disease 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
- TCT-830 Difference in Hemodynamic Micro-Environment in Vessels Scaffolded With ABSORB BVS or MIRAGE Microfiber Sirolimus Eluting Scaffold: A Pre-Clinical Study of Endothelial Shear Stress. (2016) (0)
- FIRST SEQUENTIAL ASSESSMENT AT 6 MONTHS AND 2 YEARS OF THE 2ND GENERATION ABSORB EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLD: A MULTI-IMAGING MODALITY STUDY (2012) (0)
- ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM) (2014) (0)
- TCTAP A-053 Bioabsorbable Vascular Scaffold Overexpansion Compared to Metallic Platforms: Insights from In-Vitro Experiments (2016) (0)
- TCT-8 Fate of deferred lesions using state-of-art percutaneous coronary revascularization in patients with de novo three vessel disease: lesion level analysis at 2 years of the SYNTAX II study (2018) (0)
- Syntax II and Syntax III trials: what is the take home message for surgeons? Lessons learned from the 2 year results of Syntax II (2018) (0)
- Interventional cardiology 2018: the year in review. (2019) (0)
- Association between endothelial shear stress and neointimal formation in bioresorbable vascular scaffolds. An OCT study (2013) (0)
- TCT-503 Objective Quantification of Post-TAVR Aortic Regurgitation in the Real World Using 12 Different Types of Transcatheter Heart Valves: A Multicenter Pooled Analysis (2022) (0)
- Comparison of everolimus-eluting bioresorbable scaffolds with everolimuseluting metallic stents for treatment of coronary artery stenosis: Three-year follow-up of the ABSORB II randomized trial (2017) (0)
- TCT-493 Impact of Established Cardiovascular Disease on 10-Year Death After Coronary Revascularization for Complex Coronary Artery Disease (2021) (0)
- he Unrestricted Use of Sirolimus-and aclitaxel-Eluting Stents Results in Better linical Outcomes During 6-Year Follow-Up han Bare-Metal Stents (0)
- TCT-636 Impact of Diabetes on the Outcomes in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Analysis From the GLOBAL LEADERS Study (2019) (0)
- Double chimney stenting without contrast during transcatheter aortic valve-in-valve implantation. (2022) (0)
- CORE LABORATORY ASSESSMENT OF NON-FATAL Q-WAVE MYOCARDIAL INFARCTION IN THE GLOBAL LEADERS TRIAL: METHODS AND FINDINGS (2019) (0)
- TCT-563 Fusion of intravascular ultrasound and X-ray angiography does not allow accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation. A comparison with optical coherence tomography-derived reconstructions (2013) (0)
- LONG TERM CLINICAL OUTCOMES OF SIROLIMUS AND EVEROLIMUS ELUTING STENTS IN THE ‘REAL WORLD’ TREATMENT OF PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (2012) (0)
- TCT-511 Bioresorbable polymers and paclitaxel impair endothelial regeneration by induction of autophagy (2015) (0)
- Early development of bioresorbable scaffold (2017) (0)
- TCT-40 Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND Single-arm Trial (2012) (0)
- TCTAP A-063 Endothelial Shear Stress and Vascular Remodeling in Bioresorbable Scaffold and Metallic Stent in the ABSORB II Trial (2019) (0)
- TCT-252 Impact of diabetes on angina frequency and health status outcomes after bioresorbable scaffold implantation (2017) (0)
- CRT-600.07 Feasibility and Safety of Percutaneous Intramyocardial Injection of Alginate-Hydrogel Into the Targeted Endocardial Region in a Porcine Model: A Novel Catheter-Based System X-Drop (2023) (0)
- TCT-239 Impact of Nonrespect of SYNTAX Score II Recommendations for Surgery in Patients With Complex Coronary Artery Disease Treated by PCI: A Pooled Analysis of 3,280 Randomized Patients: SYNTAX, BEST, and PRECOMBAT Trials (2019) (0)
- NON-INVASIVE FRACTIONAL FLOW RESERVE ASSESSMENT BASED ON MULTI-SLICE COMPUTED TOMOGRAPHY FIVE YEAR AFTER ABSORB BIORESORBABLE SCAFFOLD IMPLANTATION (2012) (0)
- Assessment Of Heart Team’S Treatment Decision Variability: Insights From The Syntax III Revolution Trial. (2019) (0)
- Reply: Does Repeat Revascularization Introduce Bias for Reducing Mortality in the Antiplatelet Therapy Group? (2021) (0)
- CRT-700.47 Commissural/Coronary Alignment With the Novel Myval Octacor THV - The Octa Align Technique (2023) (0)
- SEX DIFFERENCES IN OUTCOMES AFTER STENTING OR BYPASS SURGERY FOR UNPROTECTED LEFT MAIN DISEASE (2017) (0)
- The year in review 2019: Coronary interventions. (2020) (0)
- TCT-413 Different Safety Pattern of Ticagrelor Monotherapy Following Percutaneous Coronary Interventions Related to Pulse Pressure Levels: A Subanalysis of the GLOBAL LEADERS Randomized Multicenter Trial (2019) (0)
- TCT-244 Impact of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization (2021) (0)
- CRT-100.69 Does Cardiac Troponin I Overestimate Periprocedural Myocardial Infarction When Compared to Cardiac Troponin T? (2023) (0)
- TCT-166 Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial (2019) (0)
- Quantitative videodensitometric assessment of residual mitral regurgitation after transcatheter mitral valve replacement: a first-in-human report from China. (2022) (0)
- InterventionsNeed for a Reappraisal? Guidelines for Reporting Mortality and Morbidity After Cardiac Valve (2013) (0)
- Everolimus Eluting Coronary Stents: Clinical Trials (2011) (0)
- Original Studies Angiographic Assessment of Aortic Regurgitation by Video-Densitometry in the Setting of TAVI: Echocardiographic and Clinical Correlates (2017) (0)
- TCTAP A-027 Impact of Left Ventricular Ejection Fraction (EF) on 10-Year Mortality After PCI or CABG in the SYNTAXES Trial: CABG Safer Than PCI in Reduced Ejection Fraction (rEF) (2022) (0)
- P2070Three-year clinical outcomes of the bvs expand registry (2017) (0)
- Commentary regarding the article by Gragnano et al. PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY. (2020) (0)
- CRT-403 Incomplete Stent Apposition Causes High Shear Flow Disturbances And Delay In Neointimal Coverage (2015) (0)
- TCT-14 A 30-Day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) After PCI in Brazil and Japan: SYNERGY Stent With Prasugrel Monotherapy (10 mg or 3.75 mg) (2022) (0)
- Impact of diabetes mellitus on 2-year outcomes of Absorb BVS compared to Xience EES: a pooled analysis of the COMPARE-ABSORB and AIDA trial (2020) (0)
- TCT-510 Five-year true serial evaluation of jailed side branches by Absorb bioresorbable vascular scaffolds using three-dimensional optical coherence tomography (2015) (0)
- TCT-48 Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT (2019) (0)
- CORONARY INTERVENT IONS (2014) (0)
- Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study (2021) (0)
- Acute and Long-term Relocation of Minimal Lumen Area after Bioresorbable Scaffold or Metallic Stent Implantation. (2019) (0)
- TCT-109 Ten-Year All-Cause Death After Percutaneous or Surgical Revascularization in Diabetic Patients With Complex Coronary Artery Disease (2021) (0)
- TCT-183 The Impact of Atherosclerotic Plaque Type on Strut Penetration and Local Hemodynamics in Bioresorbable Scaffolds (2019) (0)
- TCTAP A-083 Incomplete Stent Apposition Causes High Shear Flow Disturbances and Delay in Neointimal Coverage as a Function of Strut to Wall Detachment Distance: Implications for Stent Optimization (2015) (0)
- TCT-519 Randomized study to assess the effect of ThRombus aspiration on flow area in STEMI patients: an Optical Frequency domain Imaging study (TROFI). Two- and Three-dimensional analysis of Six-month OFDI follow-up (2012) (0)
- The usefulness of cardiac CT integrated with FFRCT for planning myocardial revascularization in complex coronary artery disease: a lesson from SYNTAX studies. (2020) (0)
- Pitfalls of Simplifying the Original SYNTAX Score: A Temptation That Should Be Resisted. (2023) (0)
- VISUALIZATION OF THE VASCULAR EFFECTS OF THE EVEROLIMUS-ELUTING BIORESORBABLE VASCULAR SCAFFOLD WITH IN VIVO OPTICAL COHERENCE TOMOGRAPHY AND HISTOLOGY TWO YEARS AFTER IMPLANTATION IN PORCINE CORONARY ARTERIES (2011) (0)
- Do we still need to perform FFR and PCI? (2023) (0)
- TCT-118 The impact of bifurcation stenting techniques on the clinical events: the stratified analysis of 2,510 bifurcated lesions according to MADS classification in the Global LEADERS trial (2018) (0)
- TCT-191 Impact of post-procedural minimal stent area by IVUS on 2-year outcome after PCI in the SYNTAX II trial. (2018) (0)
- An optical coherence tomography and endothelial shear stress study of a novel bioresorbable bypass graft (2023) (0)
- CRT-100.02 On-Pump and Off-Pump Coronary Artery Bypass Grafting on 10-Year Mortality Versus Percutaneous Coronary Intervention (2023) (0)
- TCT-673 Two years clinical outcomes with the state-of-the-art PCI for the treatment of bifurcation lesions: A Sub-analysis of the SYNTAX II study (2018) (0)
- TCT-112 Repeat Revascularization Impact on 10-Year Survival After PCI or CABG: Post Hoc Analysis of the SYNTAXES Trial (2021) (0)
- TCT-309 Incidence and Clinical Impact of Major Infections Following PCI or CABG for Left Main Disease: Insights From the EXCEL Trial (2019) (0)
- Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease (2017) (0)
- CRT-100.23 Assessment of Minimum Stent Area and Stent Expansion and Its Relation to Ultrasonic Flow Ratio Post-Percutaneous Coronary Intervention: Insights From MULTIVESSEL TALENT Trial (2023) (0)
- CRT-500.03 Agreement of Wall Shear Stress Distribution in Three-Dimensional Quantitative Coronary Angiography Data Between Two Core Laboratories Using Automated Software for Real-Time Quantification (2023) (0)
- TCT-70 Ability of the bioresorbable vascular scaffold to re-cap the underlying plaque. A serial optical coherence tomography study (2013) (0)
- TCT-184 Diagnostic Concordance and Discordance Between Angiography-Based Quantitative Flow Ratio and Fractional Flow Reserve Derived From Computed Tomography in Complex Coronary Artery Disease (2021) (0)
- TCT-540 Impact of postdilation on procedural and clinical outcomes in long and complex lesions treated with bioresorbable vascular scaffolds- a prospective registry study (2015) (0)
- Computational Analysis of Multislice CT Angiography (2017) (0)
- Percutaneous Coronary Intervention in Multivessel Disease (2010) (0)
- TCT-179 The Influence of Increasing Stent Length on Outcomes in Absorb BVS or Xience EES-Treated Patients in Routine Clinical PCI Practice: AIDA Trial Substudy (2019) (0)
- TCT-610 Impact of Baseline Renal Function on the Long-Term Clinical Outcomes After PCI: Insights From a Prespecified Subgroup Analysis of the Randomized GLOBAL LEADERS Trial (2019) (0)
- TCT-158 Post-implantation Strut Protrusion and Neointimal Thickness at follow-up in Absorn Bioresorbable Scaffold: A serial Shear Stress Analysis Up to Five Years (2018) (0)
- TCT-581 Multislice Computed Tomography Angiography as a Non-invasive Angiographic and Functional Assessment of the 18-Months Performance of a Novel Radiolucent Bio-resorbable Coronary Scaffolding Device (ABSORB Cohort B Trial) (2012) (0)
- TCT-106 Are Outcomes Following CABG for Left Main Disease Improving Over the Last Decade? A Propensity-Matched Analysis From the EXCEL and SYNTAX Randomized Trials (2018) (0)
- Angiography-based superficial wall strain of de novo stenotic coronary arteries: serial assessment of vessels treated with bioresorbable scaffold or drug-eluting stent. (2023) (0)
- FRACTIONAL FLOW RESERVE DERIVED FROM COMPUTED TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH COMPLEX CORONARY ARTERY DISEASE: FEASIBILITY AND VALIDATION OF THE NON-INVASIVE FUNCTIONAL SYNTAX SCORE (2018) (0)
- TCTAP A-086 Can a Machine Learning Based Approach Improve Risk Prediction and Individualise Decision Making Between Percutaneous and Surgical Revascularisation in Patients With Complex Coronary Artery Disease? (2023) (0)
- P5344Clinical outcomes after primary PCI using contemporary drug eluting stents: evidence from a network meta-analysis comprising 12,639 patients (2018) (0)
- The era of single angiographic view for physiological assessment has come. Is simplification the ultimate sophistication? (2021) (0)
- The Influence of Implantation Techniques on Lesion-Oriented Outcomes in Absorb BVS and Xience EES Lesions Treated in Routine Clinical Practice at Complete Three-Year Follow-Up - AIDA Trial QCA Substudy (2021) (0)
- SEQUENTIAL OPTICAL COHERENCE TOMOGRAPHY IMAGING POST PROCEDURE, AT 6, 12, 24 AND 36 MONTHS IN THE ABSORB COHORT B TRIAL: A LIGHT INTENSITY ANALYSIS TO ASSESS THE BIORESORPTION PROCESS OF EVEROLIMUS-ELUTING PLLA SCAFFOLD (2014) (0)
- TCT-262 Screening Selection According to the SYNTAX Score 2020 in the FASTTRACK CABG—A First in Man Study—Assessing the Feasibility and Safety of Sole MSCT Guidance for CABG Performance (2022) (0)
- TCT-295 Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial (2022) (0)
- EVALUATION OF SIDE BRANCH OPENING USING THREE DIMENSIONAL VISUALIZATION OF NEW GENERATION OPTICAL COHERENCE TOMOGRAPHY AFTER BIOABSORBABLE EVEROLIMUS ELUTING STENT IMPLANTATION (2010) (0)
- Abstract 3031: Repeat Revascularisation following Multivessel Sirolimus-eluting Stent Implantation: Indications and Long-term Follow-up From the Arterial Revascularisation Therapies Study Part 2 (ARTS-II) (2008) (0)
- TCT-258 Impact of the type of the underlying plaque on the neointima tissue developed after a bioresorbable scaffold implantation. A serial optical coherence tomography study (2012) (0)
- TCT-345 Detailed Segmental Comparison Between a Dedicated Bifurcation Stent and Balloon Angioplasty Using Intravascular Ultrasound and Three-dimensional Quantitative Coronary Angiography: a Subgroup Analysis of the Tryton IDE Randomized Trial (2015) (0)
- Impact of periprocedural major adverse events on 10-year mortality after revascularisation. (2023) (0)
- Bioresorbable vascular scaffolds and late lumen loss – Authors' reply (2017) (0)
- [Nursing sequence during intra-aortic balloon pumping]. (1981) (0)
- Abstract 14590: Thrombus Aspiration and its Affect on Efficacy and Safety of Drug Eluting Stents in Acute Myocardial Infarction. (2010) (0)
- P869Predictive value of the endothelial shear stress distribution in three-dimensional quantitative coronary angiography models in detecting vulnerable plaques (2019) (0)
- [Interactions with a schizophrenic patient being treated since age 11]. (1978) (0)
- TCT-304 Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan (2022) (0)
- TCT-186 Preclinical Evaluation of a Novel Thin-Strut PLLA Bioresorbable Scaffold in Porcine Coronary Artery at 6-Month Follow-Up (2019) (0)
- QUANTIFICATION BY OPTICAL COHERENCE TOMOGRAPHY IMAGING OF THE ABLATION VOLUME OBTAINED WITH THE ORBITAL ATHERECTOMY SYSTEM IN CALCIFIED CORONARY LESIONS (2016) (0)
- TCT-324 Mortality of Stenting Versus Bypass Surgery According to Completeness of Revascularization In Severe Coronary Artery Disease: Patient-Level Pooled Analysis of SYNTAX, PRECOMBAT, and BEST Trials. (2016) (0)
- TCT-170 Endothelial Shear Stress and Vascular Remodeling in Bioresorbable Scaffold and Metallic Stent (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yoshinobu Onuma?
Yoshinobu Onuma is affiliated with the following schools:
